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Aryl hydrocarbon receptor (AHR) 
is a transcription factor aberrantly 
activated by some toxins. Its target 
genes include cytochrome P450 
(CYP) enzymes. In this thesis, 
Caenorhabditis elegans is used to 
demonstrate a role for the AHR 
ortholog AHR-1 in neuronal function, 
growth and metabolism. Moreover, 
AHR-1 and Caenorhabditis elegans 
CYP-35A subfamily members are 
shown to take part in the regulation 
of fatty acid diversity and possibly 
lipid signaling. Many of the roles 
presented here appear conserved 
in mammals and may help to 
understand mechanisms of action of 
toxins.
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ABSTRACT
Mammalian aryl hydrocarbon receptor (AHR) is a transcription factor activated by aryl
hydrocarbons including some environmental toxins. It regulates several important
physiological processes. AHR target genes include members of the cytochrome P450 (CYP)
protein superfamily. CYPs as a family metabolize a wide variety of substrates including
drugs and toxins but also endogenous compounds such as steroids and fatty acids. The
nematode Caenorhabditis elegans (C. elegans)  is  a  simple  multicellular  model  organism  that
can be used to study gene function. It has one AHR ortholog AHR-1 and 77 protein-coding
cyp genes.  While  AHR  responds  to  toxins  only  in  vertebrates,  the  physiological  roles  of
AHR and CYPs are likely evolutionarily conserved. The aim of the study was to investigate
the basic physiological roles of AHR and CYPs in C. elegans. Loss-of-function mutants were
studied using a combination of phenotyping, fatty acid profiling and transcriptomics.
Another aim was to follow the development of transcriptomics methods and their usage.
The ahr-1 mutant grew slower than wild-type and had defects in movement, egg laying
and defecation. Its fatty acid compositions, as well as gene expression levels of the enzymes
that control them, were altered. Gene expression profiles in the mutant supported the role
for AHR in development and metabolism during the first larval stage and in regulation of
neuronal function during the last larval stage. Loss of cyp-35A subfamily genes resulted in
reduction of  fat  and altered expression of  genes  encoding enzymes that  control  fatty  acid
diversity. Fatty acid compositions showed small but statistically significant changes. The
endocannabinoid N-arachidonoylethanolamine was increased in the cyp-35A5 mutant.
Feeding with the fatty acids 18:n9cis and -trans lowered the expression of cyp-35A subfamily
genes. The use of microarrays for gene expression profiling in the neurosciences has grown
until recently whereas RNA-seq is a new emerging method for this purpose.
In conclusion, the results indicate a role for AHR in neuronal development and function
as  well  as  in  growth  and  metabolism.  Both  CYPs  and  AHR  appear  to  be  involved  in  the
regulation of fatty acid diversity and possibly lipid signaling molecules. Many of the roles
of AHR and CYPs are conserved between C. elegans and mammals. These physiological
roles may help to understand the mechanisms of action of toxins and should be taken into
consideration when assessing chemicals or before developing treatments against the
adverse effects.
National Library of Medical Classification: QU 470, QU 475, QU 550.5.G4, QX 203, WH 190
Medical Subject Headings: Caenorhabditis elegans/genetics; Gene Expression Profiling; Transcription Factors;
Aryl Hydrocarbon; Cytochrome P-450 Enzyme System; Fatty Acids; Microarray analysis
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TIIVISTELMÄ
Nisäkkäiden aryylihiilivetyreseptori (AHR) on transkriptiotekijä, joka aktivoituu
aryylihiilivetyjen kuten eräiden ympäristömykkyjen vaikutuksesta. Se säätelee useita
tärkeitä fysiologisia prosesseja. AHR:n kohdegeenejä ovat mm. sytokromi P450 (CYP) -
yläperheen jäsenet. CYP:t metaboloivat perheenä monenlaisia substraatteja kuten lääkkeitä
ja toksiineja mutta myös endogeenisiä yhdisteitä kuten steroideja ja rasvahappoja.
Nematodi Caenorhabditis elegans (C. elegans) on yksinkertainen monisoluinen
malliorganismi, jota voi käyttää geenien toiminnan tutkimiseen. Sillä on yksi AHR-ortologi
AHR-1 ja 77 proteiinia koodaavaa cyp-geeniä. Vaikka AHR reagoi toksiineihin vain
selkärankaisissa, AHR:n ja CYP:ien fysiologiset roolit ovat todennäköisesti evoluutiossa
säilyneitä.  Tutkimuksen  tavoite  oli  tutkia  AHR:n  ja  CYP:ien  fysiologisia  perustehtäviä C.
elegansissa. Mutantteja, joilta puuttui toimiva geeni, tutkittiin yhdistämällä
fenotyyppianalyysiä, rasvahappoprofilointia ja transkriptomiikkaa. Toinen tavoite oli
seurata transkriptomiikan menetelmien kehitystä ja käyttöä.
ahr-1-mutantti kasvoi hitaammin kuin villityyppi, ja sillä oli häiriöitä liikkumisessa,
munimisessa ja ulostamisessa. Sen rasvahappokoostumukset ja niitä säätelevien
entsyymien geenien ilmenemistasot olivat muuttuneet. Mutantin geenien
ilmenemisprofiilit tukivat AHR:n roolia kehityksessä ja metaboliassa ensimmäisen
toukkavaiheen aikana ja neuronien toiminnan säätelyssä viimeisen toukkavaiheen aikana.
cyp-35A-aliperheen geenien puuttuminen aiheutti rasvan vähentymistä sekä
ilmenemismuutoksia geeneissä, jotka koodaavat rasvahappokoostumuksia sääteleviä
entsyymejä. Rasvahappokoostumuksissa näkyi pieniä mutta tilastollisesti merkitseviä
muutoksia. Endokannabinoidi N-arakidonoyylietanolamiinin määrä oli kasvanut cyp-35A5-
mutantissa. Rasvahappojen 18:n9cis ja  -trans syöttäminen vähensi cyp-35A-aliperheen
geenien ilmenemistasoja. Mikrosirujen käyttö geenien ilmenemisen profilointiin
neurotieteissä on kasvanut viime aikoihin saakka, kun taas RNA-seq on uusi kasvava
menetelmä tähän tarkoitukseen.
Loppupäätelmänä tulokset osoittavat, että AHR:llä on rooli hermosolujen kehityksessä ja
toiminnassa sekä kasvussa ja metaboliassa. Sekä AHR että CYP:t näyttävät liittyvän
rasvahappojen moninaisuuden ja mahdollisesti rasvasignaalimolekyylien säätelyyn. Monet
AHR:n ja CYP:ien rooleista ovat säilyneet C. elegansin ja nisäkkäiden välillä. Nämä
fysiologiset roolit voivat auttaa ymmärtämään toksiinien toimintamekanismeja, ja ne pitäisi
ottaa huomioon arvioitaessa kemikaaleja tai ennen kuin kehitetään hoitoja haitallisia
vaikutuksia vastaan.
Luokitus: QU 470, QU 475, QU 550.5.G4, QX 203, WH 190
Yleinen Suomalainen asiasanasto: sukkulamadot; geeniekspressio; transkriptiotekijät;
aryylihiilivetyreseptorit; sytokromi P-450 -entsyymijärjestelmä; rasvahapot; mikrosiruanalyysi
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1 Introduction
The field of molecular toxicology studies the effects of chemicals on living systems with the
ultimate aim to develop toxicity tests and treatments against the toxic effects of chemicals.
In this process it is essential to understand the physiological functions of the molecules that
interact with xenobiotics. Aryl hydrocarbon receptor (AHR) is a transcription factor that
regulates  the  expression  of  several  genes  by  binding  to  specific  DNA  sequences  in  their
regulatory areas. Human AHR is inappropriately activated by environmental toxic aryl
hydrocarbons. Animal knockout studies show that AHR regulates the development and
function of many systems in the body (Fernandez-Salguero et al., 1995; Schmidt et al., 1996).
Genes  regulated  by  AHR  include  some  cytochrome  P450  (CYP)  genes.  CYPs  are  a
superfamily of enzymes that metabolize various exogenous and endogenous compounds
and synthesize important signaling molecules. Chemicals from the environment or food
can  affect  gene  expression  or  enzymatic  activity  of  CYPs  and  thereby  interfere  with  their
physiological functions (Amacher, 2010).
Caenorhabditis elegans (C. elegans) is a good model organism to study functions of genes. It
is a ~1 mm long nematode with 1031 cells and a lifespan of three weeks. It is a multicellular,
yet  simple  organism  that  is  easy  to  grow,  handle  and  store.  Functions  of  genes  can  be
studied in C. elegans using e.g. loss-of-function mutants that lack the functional protein of
interest. C. elegans was  the  first  multicellular  organism  with  its  entire  genome  sequenced
and genomic microarrays are available for it. C. elegans has about 20500 protein-coding
genes, and about 38 % of them have been shown to have orthologs in human (Shaye and
Greenwald, 2011). The AHR ortholog in C. elegans is AHR-1 (Powell-Coffman et al., 1998). It
is required for normal neuronal development (Huang et al., 2004; Qin and Powell-Coffman,
2004) but the molecular mechanisms of its function are not well understood. The nematode
has  77  functional  CYPs but  a  lot  remains  to  be  known about  their  function.  According to
earlier RNA interference (RNAi) studies, some CYPs are essential for survival and
development in C. elegans (Piano et al., 2002; Kamath et al., 2003; Rual et al., 2004;
Sönnichsen et al., 2005). C. elegans can provide a model system also in molecular toxicology.
As the genomic sequence is known for an ever increasing number of organisms the
current challenge is to elucidate the flow of information from sequence to phenotype. DNA
is transcribed to RNA which is then translated to protein. These processes and their
regulation  are  often  studied  using  high  throughput  methods.  One  such  approach  is  gene
expression profiling which measures the levels of different RNA species in a tissue at a
given  time  on  the  level  of  the  whole  transcriptome.  The  most  used  gene  expression
profiling method so far is microarray technology, whereas high throughput RNA
sequencing (RNA-seq) is an upcoming method. Some proteins produce metabolites such as
lipids that are also important to the function of the cell. There is a growing interest to study
these metabolites on a global level, and methods such as mass spectrometry have facilitated
the study of cellular lipids.
In  this  thesis,  the  functions  of  AHR-1  and  CYP-35A  subfamily  members  were
investigated in C. elegans. Phenotypes were characterized in mutants lacking functional ahr-
1 or cyp-35A subfamily genes and the role of AHR-1 and CYP-35A subfamily members in
fatty acid synthesis was demonstrated by measuring overall fatty acid compositions and
gene expression alterations  in  enzymes that  control  them in  the  mutants  (II and III). The
effect of the ahr-1 mutation  on  overall  gene  expression  was  studied  by  identifying
differentially expressed genes using microarrays (II) and RNA-seq (IV). In addition, the
state of the microarray field and availability of microarray data were investigated in a
systematic review (I).
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32 Review of the literature
2.1 ARYL HYDROCARBON RECEPTOR (AHR)
Mammalian aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor that
belongs to the basic Helix-Loop-Helix/Per-Arnt-Sim (bHLH/PAS) family. It was first found
as the molecule that responds to treatment with toxic aryl hydrocarbons by inducing
enzymes that metabolize them (reviewed by Nebert et al., 1993). AHR is also generally
accepted as the main mediator of the toxic effects of these compounds through aberrant
changes in the expression of not only the well known enzymes but also several other genes
under its regulatory control. Knockout studies have shown that AHR clearly has
physiological roles beyond the toxin response, and its original ligands are thought to be
endogenous. Current research focuses on the physiological functions of AHR. The
following subsections will first review the molecular mechanisms of gene expression
regulation by AHR, ligands and other possible ways to activate AHR, physiological roles of
AHR  with  the  main  focus  on  studies  in  knockout  mice  or  cell  lines,  and  finally  the  AHR
ortholog in the nematode C. elegans.
2.1.1 Molecular mechanisms of action
The  classical  function  of  AHR  is  to  facilitate  transcription  initiation  of  its  target  genes  by
binding to their regulatory sequences in DNA. Unactivated AHR is located in the cytosol in
a protein complex that contains a dimer of the heat shock protein HSP90 (Denis et al., 1988;
Perdew, 1988), the co-chaperone p23 (Kazlauskas et al., 1999), and immunophilin-like
protein hepatitis B virus X-associated protein 2 (XAP2, Meyer et al., 1998; Ma and Whitlock,
1997; Carver and Bradfield, 1997). AHR is typically activated by a ligand that binds to its
PAS-B domain (Fukunaga et al., 1995). The ligand binding leads to nuclear translocation
and dissociation of the complex (reviewed by Beischlag et al., 2008). In the nucleus, AHR
forms a heterodimer with the AHR nuclear translocator (ARNT, Reyes et al., 1992) through
its PAS-A, PAS-B and HLH domains and the heterodimer binds to specific DNA sequences
named xenobiotic responsive elements (XREs) through the “basic” (b) region of the bHLH
domain (Fukunaga et al., 1995). AHR is exported from the nucleus and degraded via the
26S proteasome pathway (reviewed by Pollenz, 2002).
The XRE contains a core sequence to which the AHR:ARNT heterodimer binds. Denison
et al. (1988) defined the core sequence as 5’-T[A/T]GCGTG-3’ while Lusska et al. (1993)
observed  the  sequence  5’-CGTGT-3’  to  be  essential  for  AHR:ARNT  binding  and
transcription enhancement. ARNT binds to the GTG nucleotides whereas AHR binds to the
5’ portion of the XRE core (Bacsi et al., 1995). However, the core sequence, or the binding of
the AHR:ARNT heterodimer to it, is not sufficient for the transcription enhancement
function that also depends on the DNA sequence surrounding the core (Denison et al.,
1988; Lusska et al., 1993). The most studied AHR target gene is CYP1A1 that contains
multiple upstream XRE sites required for its transcription (reviewed by Whitlock, 1999).
The binding of AHR to the XRE in the CYP1A1 enhancer leads to nucleosome disruption
that makes the promoter accessible for general transcription factors (Morgan and Whitlock,
1992). AHR and ARNT interact with general transcription factors such as TATA box
binding protein (TBP) and TFIIF (Rowlands et al., 1996), subunits of the Mediator complex
(Wang et al., 2004) and several coactivators that can be histone acetyltransferases (Kumar
and Perdew, 1999; Beischlag et al., 2002), ATP-dependent histone modifiers (Wang and
Hankinson, 2002) or other types of coactivators such as the receptor-interacting protein RIP-
140 (Kumar et al., 1999; reviewed by Hankinson, 2005). Transcriptional activation by AHR
requires a transactivation domain that is a large glutamine-rich area in the C terminal
region of AHR and contains several regions that function synergistically (Fukunaga et al.,
1995; Rowlands et al., 1996; Ko et al., 1997).
AHR can also interact directly with other transcription regulator proteins to enhance or
repress  their  target  gene  expression  via  binding  to  DNA.  For  example,  AHR  forms  a
complex with the retinoblastoma protein Rb (Ge and Elferink, 1998) and the complex
represses transcription by another transcription factor E2F by binding to its promoters and
displacing the coactivator p300 (Marlowe et al., 2004). AHR can also form a complex with
E2F that induces E2F target gene expression (Watanabe et al., 2010). In addition, AHR can
recruit unliganded estrogen and androgen receptors to their DNA binding sites and
activate their target gene expression (Ohtake et al., 2003, 2008) while it has also been shown
to repress the target genes of ligand-bound estrogen receptor (Klinge et al., 1999; Ohtake et
al.,  2003).  Ligand-bound  AHR  forms  a  complex  with  the  nuclear  factor  ΎB  (NF-ΎB).  This
complex represses the target genes of both AHR and NF-ΎB (Tian et al., 1999) whereas
unliganded  AHR  can  form  a  complex  with  NF-ΎB  that  induces  NF-ΎB  target  gene
expression (Chen et al., 2012). In addition, AHR in a complex with ARNT acts as a ligand-
activated coregulator with an unknown protein that binds to a specific DNA sequence
termed XREII (Boutros et al., 2004; Sogawa et al., 2004). Similarly, other transcription factors
can modulate the expression of AHR target genes.
AHR  can  also  modulate  intracellular  signaling  pathways  without  binding  to  DNA
(reviewed by Marlowe and Puga, 2005 and Haarmann-Stemmann et al., 2009). Treatment
with the environmental model toxin 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) leads
initially to activation of cytosolic kinases before induction of AHR target genes but also
these initial effects are AHR-dependent (Enan and Matsumura, 1995; Dong and
Matsumura, 2008, 2009). Moreover, AHR  without  an  exogenous  ligand  forms  a  complex
with the D-cyclin-dependent kinase 4 that phosphorylates the retinoblastoma protein (Rb)
preventing it from repressing E2F target genes (Barhoover et al., 2010).
Another function of AHR is that it promotes proteasomal degradation of specific target
proteins such as estrogen and androgen receptors. Ligand-bound AHR recognizes the
proteins to be degraded and functions in an ubiquitin ligase E3 complex. The complex
recruits E2 ubiquitin-conjugating enzymes that add ubiquitin molecules to the target
proteins. The added ubiquitins are recognized by the 26S proteasome leading to protein
degradation (Ohtake et al., 2007, 2008, 2009).
2.1.2 Activation of AHR
AHR has several ligands, some of which are synthetic, some endogenous and some dietary.
The  most  classical  ligands  for  AHR  are  the  synthetic  and  exogenous  planary  compounds
that contain benzene rings (reviewed by Denison and Nagy, 2003 and Nguyen and
Bradfield, 2008). They include halogenated aromatic hydrocarbons (HAHs) such as TCDD,
2,3,7,8’-tetrachlorodibenzofuran, 3,3’,4,4’-tetrachloroazoxybenzene or 2,3,6,7-
tetrachloronaphtalene; polyaromatic hydrocarbons (PAHs) such as, 3-methylcholantrene,
benzo[a]pyrene or Ά-naphthoflavone; and polychlorinated biphenyls (PCBs) such as
3,4,3’,4’,5-pentachlorobiphenyl. There are also “nonclassical” synthetic AHR ligands that
typically also contain benzene rings but are somewhat different in structure (reviewed by
Denison  and  Nagy,  2003).  Among  the  known  xenobiotic  ligands,  the  HAHs  are  the  most
potent (pM to nM affinities) and TCDD is the most potent of them.
For a compound to be an endogenous AHR ligand it has to bind AHR at a relatively high
affinity and also be present in high enough concentrations, at least locally, to activate the
receptor. The local concentrations are not easy to assess and therefore most of the
endogenous AHR ligands are still putative. The endogenous ligand with the highest
affinity known is the tryptophan ultraviolet photoproduct 6-formylindolo[3,2-b]carbazole
(FICZ) that binds AHR as well or even better than the prototypical xenobiotic AHR ligand
TCDD (Rannug,  et  al.,  1987,  1995).  FICZ synthesis  can be  induced by UV-B light  in  a  cell
culture (Fritsche et al., 2007) and FICZ metabolites have been detected in human urine
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substrate of CYP1A1, an enzyme whose expression it induces through AHR, resulting in an
autoregulatory loop (Wei et al., 2000). This resembles the “detoxification response” function
of AHR in which xenobiotic AHR ligands induce genes that metabolize them. Other
endogenous ligands include other tryptophan metabolites, indigoids, heme metabolites, 2-
(1’H-indole-3’-carbonyl)-thiazole-4-carboxylic acid methyl ester, equilenin (horse estrogen),
and the arachidonic acid metabolites lipoxin A4 and prostaglandin G (reviewed by Denison
and Nagy, 2003 and Nguyen and Bradfield, 2008).
In addition, many of the naturally occurring AHR ligands are obtained from diet. These
include carotinoids, flavonoids, 7,8-dihydrocutacarbine, dibenzoylmethanes, curcumin and
indolo-3-carbinol that is metabolized to e.g. indolo[3,2-b]carbazole (ICZ) that resembles
FICZ and binds AHR almost as well as TCDD (reviewed by Denison and Nagy, 2003 and
Nguyen and Bradfield, 2008). Also the naturally occurring AHR ligands typically contain
benzene rings but they can vary in their molecular structure (reviewed by Denison and
Nagy, 2003). Some natural compounds such as certain flavonoids, resveratrol (Casper et al.,
1999) or 7-ketocholesterol (Savouret et al., 2001) bind to AHR but are antagonists rather
than agonists.
There is discussion whether AHR can also be activated without binding to any ligand.
Suspension of cell cultures that reduces cell adhesion, alters cell shape and influences
differentiation (Sadek and Allen-Hoffmann, 1994a and b; Monk et al., 2001), sparse cell
density (Ikuta et al., 2004) or disruption of cell-cell contact (Cho et al., 2004) can activate
AHR and its target gene expression. In addition, shear stress-modified low-density
lipoprotein (LDL) can activate AHR (McMillan and Bradfield, 2004) although it is very
different  in  structure  and many times  larger  than all  of  the  known AHR ligands.  AHR is
also  activated by high glucose  in  a  culture  of  endothelial  cells  and forms a  complex with
other glucose-activated transcription factors that have putative binding sites near the
binding sites of AHR (Dabir et al., 2008). The activation of the complex involves
glycosylation  of  at  least  one  of  the  proteins.  Moreover,  cAMP  has  been  shown  to  induce
nuclear translocation of AHR and formation of a complex somewhat different than when
AHR is activated by TCDD (Oesch-Bartlomowicz et al., 2005). However, involvement of an
unidentified  endogenous  ligand  cannot  be  completely  ruled  out  in  any  of  these  cases.
Phosphorylation  of  AHR  by  kinases  such  as  protein  kinase  C  (Carrier  et  al.,  1992)  or
mitogen-activated protein kinases (Tan et al., 2002) has been shown to be necessary for
AHR activation although it may not be sufficient (reviewed by Puga et al., 2009).
2.1.3 Physiological roles of AHR
Studies in knock-out animals have demonstrated that AHR has many important
physiological roles. The earliest studies reported slow growth, liver defects such as smaller
size, fibrosis and fatty metamorphosis, increased formation of blood cells and lower basal
expression or uninducibility of enzymes (Fernandez-Salguero et al., 1995; Gonzalez et al.,
1995; Schmidt et al., 1996). The liver defects may be due to accumulated retinoid levels
caused by downregulation of CYP enzymes (Andreola et al., 1997, 2004a and b), increased
levels of transforming growth factor Ά (TGF-Ά, Zaher et al., 1998) or abnormal liver
vasculature development (Lahvis et al., 2000, 2005; Walisser et al., 2004; Harstad et al.,
2006).
Abnormal angiogenesis has been reported in AHR knockouts also in ischemia (Ichihara
et al., 2007) or tumorigenesis models (Fritz et al., 2007, 2008; Roman et al., 2009). In
addition, AHR knockouts have cardiac hypertrophy and fibrosis (Fernandez-Salguero et al.,
1997, Thackaberry et al., 2002; Vasquez et al., 2003). It  may  be  due  to  increased  levels  of
hypoxia-inducible factor-1΅, (Thackaberry et al., 2002) or endothelin-1 (Lund et al., 2006)
that increases reactive oxygen species in the heart (Lund et al., 2005) or decrease in the
proto-oncogene Vav3 (Sauzeau et al., 2011). AHR knockout also affects blood pressure.
Studies report both hypertension (Lund et al., 2003, 2008; Villalobos-Molina et al., 2008) and
hypotension (Zhang et al., 2010; Agbor et al., 2011) depending on e.g. altitude (Lund et al.,
2008) as well as on the levels and responsiveness to angiotensin II.
One of the two knockout strains also had neonatal lethality and immune system defects
(Fernandez-Salguero et al., 1995; Gonzalez et al., 1995). Several studies show that AHR
knockouts have reduced numbers of some types of immune system cells due to impaired
formation or increased apoptosis (Gasiewicz et al., 2000; Veldhoen et al., 2009; Jux et al.,
2009; Elizondo et al., 2011; Kadow et al., 2011; Singh et al., 2011, 2014; Qiu et al., 2012; Zhou
et al., 2013) whereas other types of immune system cells are formed in excess in the
knockouts (Singh et al., 2011; Liu et al., 2013; Qiu et al., 2013; Gasiewicz et al., 2014). Certain
types of immune system cells secrete interleukins that promote the development of other
cells of the immune system. In AHR knockouts, some interleukins are increased
(Rodríguez-Sosa et al. 2005; Shi et al., 2007; Sekine et al., 2009; Elizondo et al., 2011) and
some decreased (Veldhoen et al., 2009; Elizondo et al., 2011) and some interleukin genes are
direct targets of AHR (Jeon and Esser, 2000). AHR knockouts are usually more susceptible
to infections but in some cells the lack of AHR can protect from autoimmunity (Nakahama
et al., 2011).
AHR knockout mice also have several reproductive defects. AHR knockout females have
lesions in the uterus (Fernandez-Salguero et al., 1997) and decreased survival during
pregnancy or lactation. Many the knockout pups also die during pregnancy or lactation
(Abbott  et  al.,  1999).  AHR  knockout  females  have  a  larger  number  of  primordial  follicles
after birth (Benedict et al., 2000; Robles, et al., 2000) but a smaller number of antral follicles
later in life (Benedict et al., 2000, 2003). The AHR defieciency decreases follicular growth
and ovulation (Benedict et al., 2003; Barnett et al., 2007a), levels of estrogen and its receptors
and follicular expression of genes promoting cell cycle (Barnett et al., 2007a; Hernández-
Ochoa et al., 2010). Ovaries of AHR knockouts are also less responsive to pituitary
gonadotropins (Barnett et al., 2007b; Hernández-Ochoa et al., 2013). Male AHR knockout
mice have impaired prostate and seminal vesicle development (Lin et al., 2002). AHR is also
required in normal sperm development (Baba et al., 2008; Hansen et al., 2014). In addition,
AHR knockouts exhibit age-dependent regression of seminal vesicles, low testosterone
levels, abnormal vaginal plugs and low fertility (Baba et al., 2008).
AHR knockout also causes some defects in the development and function of the nervous
system. The knockout has reduced GABA receptor subtype A΅6 expression in the
cerebellum (Collins et al., 2008) and decreased GABAergic neuron differentiation in the
ventral telencephalon (Gohlke et al., 2009). AHR knockout mice display impaired
hippocampal-dependent memory as well as decreased formation, survival and
differentiation of neurons in the dentate gyrus (Latchney et al., 2013). AHR knockout also
causes involuntary eye movements due to visual or visuo-motor defects (Chevallier et al.,
2013).
The endogenous AHR ligand FICZ is formed by UV-B irradiation in skin cells. UV-B
causes a stress response in keratinocytes (Fritsche et al., 2007), a tanning response in
melanocytes (Jux et al., 2011) and local immunosuppression (Navid et al., 2013) through
activation of AHR. AHR knockout keratinocytes are also more susceptible to UVB-induced
apoptosis than wild-type cells (Frauenstein et al., 2013). In addition, activation of AHR by
FICZ and other  tryptophan photoproduct  ligands may play a  role  in  the  circadian timing
system in the brain, possibly by mediating a response to light. FICZ alters the circadian
expression of clock genes in a suprachiasmatic nucleus cell line and inhibits glucose-
induced shift in electrical activity rhythm in brain slices (Mukai and Tischkau, 2007). AHR
knockout mice have an increased response to light (Xu et al., 2013) whereas xenobiotic AHR
agonists decrease light-induced phase shifts in wild-type (Mukai et al., 2008; Xu et al.,
2013).
Activation of AHR affects body weight and fat mass. HAHs such as TCDD typically
cause  a  wasting syndrome with decreased weight  and fat  mass  (reviewed by Poland and
Knutson, 1982) whereas PCBs have been obesogenic in some studies (Arsenescu et al., 2008;
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7Rashid et al., 2013; Wahlang et al., 2013). AHR activation inhibits adipocyte differentiation
and fat storage in mouse-derived cell culture systems (Phillips et al., 1995; Brodie et al.,
1996; Alexander et al., 1998; Shimada et al., 2009). Another toxic effect of AHR activation is
hepatic steatosis (reviewed by Poland and Knutson, 1982) through increased fatty acid
uptake in the liver (Lee et al., 2010; Kawano et al., 2010, He et al., 2011; Angrish et al., 2012).
AHR agonist treatment also alters lipid compositions in the liver, serum and adipose tissue
(Angrish et al., 2011, 2013; Forgacs et al., 2012) as well as the expression of fatty acid
transport, metabolism and synthesis genes (Boverhof et al., 2005; Sato et al., 2008; Forgacs et
al., 2012; Wahlang et al., 2013). Moreover, mice with low-affinity AHR are less susceptible
to diet-induced obesity than mice with a high-affinity AHR (Kerley-Hamilton et al., 2012).
AHR knockouts are often resistant to the toxic effects caused by treatment with
xenobiotic AHR agonists (Fernandez-Salguero et al., 1996; Mimura et al., 1997; Dertinger et
al., 1998; Peters et al., 1999; Shimizu et al., 2000; Vorderstrasse  et al., 2001; Nakatsuru et al.,
2004; Mulero-Navarro et al., 2005; Sagredo et al., 2006; Talaska et al., 2006; Curran et al.,
2011, 2012; Lee and Riddick, 2012; Mejia-Garcia et al., 2013). However, AHR knockout
affects many of the same biological processes as the xenobiotic ligands (reviewed by Poland
and Knutson, 1982 and Bock and Köhle, 2006).
As a summary, the lack of functional AHR affects many systems in the body. This can be
due  to  defects  in  other  systems  on  the  organ  level,  defects  in  cell  cycle,  differentiation  or
apoptosis, differential expression of AHR target genes, lack of metabolism of specific
compounds, or interference with hormonal systems.
2.1.4 C. elegans AHR
The ortholog of AHR in C. elegans is AHR called AHR-1 (aryl hydrocarbon receptor-related,
Powell-Coffman et al., 1998). The AHR-1 peptide is ~600 amino acids long and shares
approximately 38 % identity with human AHR over the first 400 amino acids including the
bHLH, PAS-A and PAS-B domains while the carboxyterminals are less similar. C. elegans
AHR-1 does not have a similar glutamine-rich transcriptional activation domain as in
mammalian AHR. However, carboxyterminal regions are likely required for transcriptional
activation as suggested by experiments in a yeast expression system.
Orthologs for ARNT and HSP90 are also found in C. elegans, called AHA-1 (Powell-
Coffman et al., 1998) and DAF-21 (Birnby et al., 2000), respectively. AHR-1 and AHA-1 bind
as a dimer to the XRE core sequence TGCGTG in vitro. The binding is sequence-specific as
the  AHR-1-AHA-1  dimer  does  not  bind  to  a  modified  XRE  core  sequence  with  one  G
nucleotide changed to A. Inter-species complex formation is also possible in vitro: C. elegans
AHA-1 can form a complex with murine AHR and bind to DNA. Similarly, C. elegans AHR-
1 can form a heterodimer with human ARNT that binds to the XRE. In addition, C. elegans
AHR-1 binds to rabbit HSP90 (Powell-Coffman et al., 1998) but not to mouse XAP2 (Bell
and Poland, 2000).
The main difference between the nematode and human AHR proteins is that C. elegans
AHR-1 does not bind a TCDD analog 125IN3Br2DD and is not activated by Ά-naphthoflavone
in a yeast expression system (Powell-Coffman et al., 1998). In fact, none of the known
invertebrate AHR orthologs in Drosophila melanogaster and Mya arenaria (soft cell clam),
appear to bind TCDD or Ά-naphthoflavone (Butler et al., 2001; Crews and Brenman, 2006).
Moreover, a metabolic response to xenobiotics in the study by Jones et al. (2013) was not
dependent on AHR-1. This suggests that the ancestral role of AHR is not in adaptive toxin
response. Neither exogenous nor endogenous ligands are currently known for invertebrate
AHR. C. elegans AHR-1 is not constitutively active in a yeast expression system unless the
PAS domain is removed (Powell-Coffman et al., 1998). This suggests that AHR-1 requires
some kind of post-translational activation. However, it is not known whether the activation
is achieved through a ligand or another mechanism. If there are ligands for C. elegans AHR-
1 they are likely different from those in mammals.
The ahr-1 gene is expressed in various neurons, blast cells and phasmid socket cells
during embryogenesis and larval development (Qin and Powell-Coffman, 2004). The
neurons are of various types and utilize different neurotransmitters (Table 1). Blast cells are
precursor cells destined to divide some time after hatching. Phasmid socket cells envelop
sensory neurons in a posterior sensory structure called phasmid.
Table 1. C. elegans neurons that express ahr-1. A question mark indicates that the
neurotransmitter has not been confirmed.
Neuron Location Neurotransmitter Type
ALNR/ALNL tail acetylcholine sensory (oxygen)
AQR/PQR pharynx and tail unknown sensory (oxygen)
AVM/PVM anterior body glutamate sensory (touch)
BDUR/BDUL anterior body neuropeptide-like proteins interneurons
PLMR/PLML tail glutamate sensory (touch)
PLNR/PLNL tail acetylcholine interneurons
PHCL/PHCR tail dopamine sensory (temperature)
PVWL/PVWR tail unknown interneurons
RMEL/RMER nerve ring GABA motor
SDQR anterior body unknown interneuron
SDQL posterior body unknown interneuron
URXR/URXL head neuropeptide-like proteins sensory (oxygen)
M1 pharynx acetylcholine? motor
I3 pharynx neuropeptide-like protein? interneuron
ASKL/ASKR head glutamate sensory (chemo)
RIPL/RIPR ring/pharynx unknown interneurons
Mutations of AHR-1 affect several aspects of neuronal development (Huang et al., 2004;
Qin and Powell-Coffman, 2004; Smith et al., 2013). For example, AHR-1 is required for the
cell fate of GABAergic neurons in the L1 larval stage (Huang et al., 2004). The four
GABAergic RME neurons in the nerve ring control head muscle movements in foraging
behavior.  AHR-1  is  expressed  in  two  of  them,  namely  RMEL  and  RMER,  but  not  in  the
other  two,  i.e.  RMED  and  RMEV.  These  neurons  can  be  distinguished  based  on  their
morphology and expression of marker genes: RMED and RMEV have posteriorly extending
neuronal  processes  that  RMEL  and  RMER  do  not  have.  Moreover,  RMEL  and  RMER
express lim-6 and glr-1 whereas RMED and RMEV express avr-15. In the ahr-1(ju145)
mutant, RMEL and RMER have the neuronal processes and marker gene expression typical
of  RMED  and  RMEV.  Ectopic  expression  of ahr-1 in  all  RME  neurons  rescues  the
abnormalities seen in RMEL and RMER but in addition it causes RMED and RMEV to
develop into cells with typical RMEL and RMER morphology and marker gene expression.
The presence of AHA-1 is required for the AHR-1 function in specifying RME cell fate
whereas DAF-12 is not required.
AHR also specifies the fate of AVM light touch sensory neuron (Smith et al., 2013). In
ahr-1 mutants the AVM neuron that normally has one simple unbranched process develops
into a PVD-like nociceptor neuron with highly branched dendrites. AHR elevates the
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target genes such as hpo-30 that promotes denritic branching in PVD and in the abnormal
AVM neuron. The ahr-1 mutant has a weakened response to light touch of the anterior
body. Instead, the abnormal AVM neuron responds to similar nociceptive stimuli as the
PVD neuron and also evokes an escape response although it forms synapses with different
neurons than PVD.
AHR-1 also appears to play a role in the regulation of cell and axon migration of certain
neuron subtypes (Qin and Powell-Coffman, 2004). In the ahr-1(ia03) mutant,  AVM, SDQR
and PLM neurons or their precursors fail to migrate to their correct position during the L1
larval stage more often than in wild-type. Qin and Powell-Coffman (2004) observed SDQR
and AVM neurons to extend incorrectly projected axons and AVM to grow branched or too
many axons in the ahr-1(ia03) mutant. This may be at least partially due to differentiation of
these cells into PVD-like neurons as reported by Smith et al. (2013). In rare cases the ahr-
1(ia03) mutant also has an extra neuron that expresses the PLM neuron marker mec-18:GFP,
probably due to lineage defects or disrupted apoptosis in the mutant (Qin and Powell-
Coffman, 2004). Also AHA-1 function is required at least in SDQR migration. In addition,
AHR-1 and AHA-1 are required for gap junction contact formation between BDU and PLM
neurons (Zhang et al., 2013).
Qin et al. (2006) demonstrated that AHR-1 is involved in social feeding behavior in
which nematodes form groups on the border of the bacterial lawn (de Bono and Bargmann,
1998). The ahr-1 gene is expressed in four neurons that play a role in the regulation of social
feeding behavior, namely URXR, URXL, AQR and PQR. Social feeding is regulated by
nutrition  and  oxygen  availability  and  inhibited  by  the  neuropeptide  receptor  NPR-1  that
suppresses  the  function  of  these  neurons.  Unlike  wild-type  N2  animals, npr-1 loss-of-
function mutants are social feeders in normal laboratory conditions. Loss-of-function of ahr-
1 or aha-1 dramatically decreases social feeding of the npr-1 mutants  (Qin  and  Powell-
Coffman, 2004, Qin et al., 2006). Transgenic expression of the ahr-1 gene in only URX and
two other neurons greatly increases social feeding in the ahr-1; npr-1 double mutant
suggesting that ahr-1 is required mainly in the URX neurons to regulate social feeding but
may also function in other neurons to modulate the behavior. Induction of the ahr-1
transgene after the development of the URX neurons partially restores social feeding in the
ahr-1; npr-1 double mutant. This suggests that the suppression of social feeding behavior in
the double mutant is not due to irreversible developmental defects in URX neurons.
The URX neurons in the ahr-1 mutant develop normal morphologies but express
decreased levels of their specific marker genes npr-1 and gcy-32 as well as other gcy family
genes gcy-34, gcy-35, gcy-36 and gcy-37 as seen with gcy::GFP reporter genes. The gcy family
genes encode soluble guanylate cyclases that synthesize 3’,5’-cyclic guanosine
monophosphate (cGMP). cGMP activates TAX-2/TAX-4 cGMP-gated sensory channels that
promote social feeding in URX neurons (Coates and de Bono, 2002). Especially GCY-35 and
GCY-36 may be key regulators of social feeding as GCY-35 likely acts as an oxygen sensor
and functions as a heterodimer with GCY-36. However, transgenic expression of gcy-35 and
gcy-36 in URX neurons is not sufficient to increase social feeding in the ahr-1; npr-1 double
mutant. Thus, the regulation of these two genes is not the only mechanism through which
AHR-1 regulates social feeding but AHR-1 may regulate other genes important for the
behavior. Also the mechanism through which AHR-1 regulates the expression of gcy-35 and
gcy-36 genes is unclear. The 5’ flanking sequences of the gcy family genes contain putative
XRE elements. However, even when mutations are induced in the XRE elements of gcy-
35::GFP or gcy-36::GFP reporter constructs GFP is still  expressed in wild-type background
and under-expressed in ahr-1 mutant background suggesting that the regulation of gcy-35
or gcy-36 by AHR-1 does not occur through the putative XRE sites.
In conclusion: AHR is an evolutionarily old protein that has been present before the
divergence of vertebrates and invertebrates but toxin response is a relatively new function
only seen in vertebrates. The old functions of AHR may include development but also
regulation of behavior in response to environmental cues as the study concerning social
feeding suggests. The activation of AHR in invertebrates is still a mystery. C. elegans
provides a simple model system for studying the evolutionarily old and possibly conserved
functions of AHR.
2.2 CYTOCHROMES P450 (CYPS)
Cytochromes P450 (CYPs) are a superfamily of mono-oxygenase enzymes that are found in
virtually all organisms including animals, plants, fungi, protists, bacteria, archaea and
viruses (Gotoh, 2012). In eukaryotes they are expressed in mitochondrial membranes and
endoplasmic reticulum whereas in prokaryotes they are soluble proteins. CYPs are known
to oxidize a wide variety of both endogenous and exogenous compounds. From a
toxicological perspective, understanding of the endogenous functions of CYPs is important
as the induction of these enzymes with xenobiotics is likely to affect the physiological
processes involving CYPs (Amacher, 2010). The following subsections will provide an
overview of general CYP structure and function, evolutionarily prospects,  role of CYPs in
metabolizing endogenous compounds and C. elegans CYPs.
2.2.1 Structure and general function
The CYPs consist of an apoprotein and an iron protoporphyrin IX as a prosthetic group
(reviewed by Werck-Reichhart and Feyereisen, 2000). The protoporphyrin has an iron ion in
the middle whose oxidation-reduction cycle is involved in the catalysis of reactions.
Cytochrome P450s were named after their absorbance maximum at 450 nm when the iron
ion is in the Fe2+ form and the heme is in a complex with carbon monoxide. The core
domain binding the protoporphyrin group located near the C terminus of the protein is
highly conserved whereas other parts can vary greatly between different CYP proteins. A
CYP protein contains several recognition sites for substrates. Even small mutations in these
domains can result in the recognition of different substrates and the production of different
metabolites. In addition, CYP proteins contain binding sites for the cytochrome b5 and
NADPH-P450 reductase that provide electrons for the reactions catalyzed by CYPs, sites
that can be phosphorylated by cAMP and a membrane insertion sequence through which
the protein is attached to the endoplasmic reticulum or mitochondrial membrane.
General types of CYP-mediated reactions have been identified and include
hydroxylations, epoxidations, demethylation, oxidative deamination, oxidation, oxidative
dehalogenation and many others (reviewed by Guengerich, 2001). Generally, one atom of
oxygen is incorporated into the substrate. CYPs perform phase I metabolism of drugs and
toxins. In these reactions the substrate is prepared for Phase II metabolism enzymes.
Sometimes the effect is detoxifying, sometimes bioactivating.
CYPs are regulated at the gene expression level by their substrates that activate
transcription factors. Transcription factors known to activate CYPs include at least AHR,
pregnane X receptor (PXR), constitutive androstane receptor (CAR), peroxisome
proliferator-activated receptors (PPAR), farnesoid X receptor (FXR), liver X receptor (LXR),
hepatic nuclear factors (HNF), glucocorticoid receptor (GR) and CCAAT/enhancer binding
proteins (C/EBPs, reviewed by Tompkins and Wallace, 2007). The main xenobiotic-
activated transcription factors that induce CYPs are AHR, CAR and PXR (Pelkonen et al.,
2008; Amacher, 2010). Also endogenous substrates induce CYP gene expression through
transcription factors. For example, steroid and growth hormones have been shown to
regulate CYP gene expression (Waxman, 1988; Waxman et al., 1991) and retinoids activate
retinoid X / vitamin D (RXR/VDR) receptors that induce CYP3A4 (Wang et al., 2008).
2.2.2 Evolution of CYPs
Currently more than 16000 CYP proteins are known (Gotoh, 2012). They are found in a
wide variety of organisms including animals, plants, fungi, protists, bacteria, archaea and
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viruses,  although some species such as Escherichia coli bacteria lack them. The diversity of
CYPs has arisen through gene duplications and probably gene amplifications, conversions,
genome duplications, gene loss and lateral transfer (Werck-Reichhart and Feyereisen, 2000).
In CYP nomenclature, the first number denotes the CYP family and the following letter
denotes the subfamily (Nelson, 2006). CYPs within the same family share 40 % identity in
peptide  sequence  whereas  CYPs  within  a  subfamily  have  at  least  55  %  similarity  (Gotoh,
2012). The last number identifies the CYP protein. CYP proteins may share as little as 16 %
similarity according to an early review (Werck-Reichhart and Feyereisen, 2000). Humans
have 57 functional CYPs and more than 59 CYP pseudogenes classified in 18 families and
43 subfamilies (Gotoh, 2012). The CYP battery in human is highly conserved among
mammals and even among vertebrates. The largest CYP families in human are 2, 3 and 4,
and some of these are even larger in other mammals such as mouse.
CYP families in different phyla, e.g. vertebrates, nematodes and insects, can be grouped
into  clans  based  on  similarity  (Nelson,  1998).  CYPs  within  a  clan  may  be  derived  from  a
single ancestor. Eleven animal CYP clans have been identified in total (Nelson et al., 2013).
Humans likely have CYPs of the clans 2, 3, 4, 7, 19, 20, 26, 46, 51 and mitochondrial whereas
nematodes and insects have CYPs belonging to clans 2, 3, 4 and mitochondrial (Baldwin et
al., 2009). In human and nematodes, the largest CYP clan is 2, whereas in insects clan 3 is
the  largest.  CYPs  can  also  be  classified  on  an  even  higher  level  into  groups  that  contain
similar CYP clans across e.g. animals, plants and bacteria (Gotoh, 2012). In addition, all
CYPs belong to one of the two major classes, B and E. The class B is specific to prokaryotes
and fungi, whereas CYPs of the class E are found in all organisms.
CYP families have emerged and been lost during evolution. One interesting CYP family
is CYP51 required for one step of cholesterol synthesis. This family is evolutionarily old and
found e.g. in bacteria, plants and human. However, it is not found in nematodes or insects
that do not synthesize cholesterol de novo.
Some CYPs and transcription factors that control their expression or bind ligands
synthesized by them may have evolved together. This has been shown for steroid hormone
receptors and the CYP19A1 that synthesizes estrogen (reviewed by Gotoh, 2012). Whether
it is true in the case of AHR and CYP1A1 is currently not known.
Some CYP families or subfamilies are phylogenetically stable typically having only one
or a few members conserved across many species, whereas unstable CYP families have
variable numbers of members in different species. It is believed that the stable CYP families
are essential in the synthesis or degradation of endogenous substrates while the highly
diverse CYP families metabolize xenobiotics or secondary metabolites (Thomas, 2007;
Gotoh,  2012).  CYPs  that  have  endogenous  substrates  typically  do  not  have  many  point
mutations leading to amino acid alterations in their substrate recognition sites, whereas
CYP families involved in xenobiotic metabolism such as CYP2 and CYP3 accumulate such
mutations. There is evidence that CYPs originally metabolizing endogenous compounds
have developed into CYPs that metabolize xenobiotics but Gotoh (2012) suggests that the
opposite may be even more likely.
2.2.3 Physiological roles of CYPs
All mammalian CYP families metabolize endogenous substrates while xenobiotic
metabolism is mainly carried out by families 1 to 4 (reviewed by Nebert et al., 2013).
Generally, the substrates that CYPs biosynthesize, bioactivate, modify or catabolize are
lipophilic. Some CYPs are essential for the production of endogenous compounds. For
example, CYP51A1 is a lanosterol 14΅-demethylase required in cholesterol biosynthesis
(Strömstedt et al., 1996). Also several other steps in the production of different steroid
hormones are dependent on CYPs (reviewed by Hu et al., 2010). CYP11A1 converts
cholesterol to pregnenolone by side-chain cleavage and CYP17A1 catalyzes subsequent
intermediate steps. CYP19A1 (aromatase) converts androgens to estrogens whereas
CYP21A2 and CYP11B1 catalyze reactions in a different pathway leading to glucocorticoids
that CYP11B2 further converts to aldosterone. Sex steroids are also catabolized by members
of the CYP3A subfamily (Waxman et al., 1988; Domanski et al., 2001). In addition,
cholesterol is also a precursor of bile acids, and CYPs 7A1, 8B1, 27A1, 7B1, 46A1 and 39A1
are involved in the pathways of their synthesis (Lorbek et al., 2012). CYPs 27A1, 27B1 and
2R1 are required for the bioactivation of vitamin D (Wikvall, 2001) whereas CYP24A1
degrades it (reviewed by Jones et al., 2012). Some CYPs synthesize retinoic acid (Zhang et
al., 2000) and others such as CYP26A1, CYP26B1 and CYP26C1 inactivate it by
hydroxylation (Ross and Zolfaghari, 2011).
CYPs also metabolize fatty acids and lipid signaling molecules. Fatty acids released from
membrane lipids by e.g. phopholipases can be converted into different classes of signaling
molecules by e.g. cyclo-oxygenases (COXs), lipoxygenases (LOXs) and CYPs. CYPs
typically metabolize fatty acids into hydroxyl and epoxy products that are called
hydroxyeicosatetraenoic acids (HETEs) and epoxyeicosatrienoic acids (EETs), respectively.
CYPs have been shown to metabolize several fatty acids including at least arachidonic acid
(20:4n6), docosahexaenoic acid (22:6n3), linoleic acid (18:2n6), ΅-linoleic acid (18:3n3),
eicosapentaenoic acid (20:5n3) and adrenic acid (22:4n6, Konkel and Schunck, 2011). CYPs
can also further metabolize the fatty acid-derived signaling molecules made by CYPs or
other enzymes (reviewed by Nebert and Karp, 2008). CYP  families  responsible  for  the
metabolism of fatty acids and their derivatives are CYP1, CYP2, CYP3 and CYP4, of which
especially the subfamilies CYPs 1A1 and 1B1 are induced by AHR (reviewed by Nebert and
Karp, 2008). The HETEs and EETs are potent signaling mediators and have a major role in
cardiovascular and nervous systems (Iliff et al., 2010). They can activate ion channels, G
protein-coupled receptors and PPAR nuclear receptors, some of which belong to the
endocannabinoid system. For example, arachidonic acid can be epoxidized by CYPs into
EETs that relax vascular smooth muscles through the activation of transient receptor
potential vanilloid type 4 (TRPV4) receptors (Watanabe et al., 2003) or into 2-
epoxyeicosatrienoylglycerols (2-EG) that activate CB2 and CB2 cannabinoid receptors
(Chen et al., 2008).
CYPs can also metabolize the endocannabinoid N-arachidonoylethanolamine (AEA) that
is a fatty acid-containing signaling molecule derived from membrane phopholipids.
Bornheim et al. (1995) found that liver and brain microsomes metabolize AEA into several
unidentified products and the metabolism is carried out by at least CYPs from subfamilies
3A, 1A and 2C. Snider et al., (2007) demonstrated that CYP4F2 hydroxylates AEA into 20-
HETE-ethanolamide (20-HETE-EA) in human liver and kidney microsomes, whereas
CYP3A4 epoxidizes it into four different epoxyeicosatetraenoic ethanolamides (EET-EAs).
Also the brain mitochondrial CYP2D6 metabolizes AEA into the same products (Snider et
al., 2008). One of the products, 5,6-EET-EA is a potent agonist of CB2 cannabinoid receptors
and more stable than AEA (Snider et al., 2009). Individuals have different alleles of the
CYP3A4 gene, and proteins from the different alleles have been shown to oxidize AEA into
different products (Pratt-Hyatt et al., 2010). In addition, CYP4X1 converts AEA into 14,15-
EET ethanolamide (14,15-EET-EA, Stark et al., 2008). CYPs also metabolize another
endocannabinoid, 2-arachidonoylglycerol (2-AG), into glycerated epoxyeicosatrienoic acids
(GEETs) that have vasodilatory functions (Awumey et al., 2008).
2.2.4 C. elegans CYPs
C. elegans has 83 cyp genes of which 77 are protein-coding and 5 are pseudogenes. The CYPs
can  be  classified  into  16  families  and  26  subfamilies.  Almost  all  of  the C. elegans CYP
families appear to be nematode-specific (Nelson, 1998) but they correspond to the clans 2, 3,
4  and  mitochondrial  found  also  in  human  (Baldwin  et  al,  2009).  The  clan  2  is  highly
expanded in C. elegans (Gotoh, 1998; Nelson, 1998) whereas only one C. elegans cyp, cyp-
44A1, belongs  to  the  mitochondrial  clan.  The  same  CYP  clans  are  found  also  in  other
protostomes including insects (Feyereisen, 2006) supporting the theory that these CYP clans
12
13
diverged before the lines leading to nematodes and human (protostomes and
deuterostomes) diverged about 670 million years ago (Ayala et al., 1998).
CYPs are required in several important physiological processes. The silencing of single
cyp genes with RNAi causes alterations in survival, morphology, embryonic development,
growth, larval development, dauer formation, life span, reproduction, movement,
pharyngeal pumping, lawn leaving behavior, fat content, lipid composition and
metabolism (Albert and Riddle, 1988; Jia et al., 2002; Piano et al., 2002; Ashrafi et al., 2003;
Kamath et al., 2003; Murphy et al., 2003; Simmer et al., 2003; Rual et al., 2004; Sönnichsen et
al., 2005; Kraemer et al., 2006; Ruaud and Bessereau, 2006; Ceron et al., 2007; Cui et al., 2007;
Kim and Sun, 2007; Samuelson et al., 2007; Kinchen et al., 2008; Kleemann et al., 2008;
Benenati et al., 2009; Coolon et al., 2009; Hannich et al., 2009; Schäfer et al., 2009; Sharma et
al., 2009; Jensen et al, 2010; Jeong et al., 2010; Karp and Ambros, 2011; Kashyap et al., 2012).
For example, the silencing of the cyp genes 31A2 and 31A3 leads to failures in meiosis and
embryonic development and they synthesize lipids that are essential for correct formation
of eggshell (Benenati et al., 2009). In addition, CYP-31A2 is required in sperm motility
(Kubagawa et al., 2006) and it negatively regulates the synthesis of prostaglandins (Hoang
et al., 2013). CYPs are also involved in aging as several cyp genes are upregulated in dauer
larvae and in long-lived daf-2 mutants (McElwee et al., 2004).
One C. elegans CYP is known to be steroidogenic: CYP-22A1 a.k.a. DAF-9. It makes
cholesterol-derived compounds such as dafachronic acids (Motola et al., 2006) and
cholestenoic acids (Held et al., 2006) that act as ligands of the the nuclear hormone receptor
DAF-12. CYP-22A1/DAF-9 plays in several pathways controlling e.g. dauer formation
(Albert and Riddle, 1988), life span and gonadal migration (Gerisch et al., 2001; Jia et al.,
2002).
Some C. elegans CYPs also synthesize fatty acid-derived signaling molecules (Kulas et al.,
2008; Kosel et al., 2011). Especially CYP-29A3 and CYP-33E2 related to mammalian CYP2
and CYP2 families, respectively, metabolize the fatty acids eicosapentaenoic acid and
arachidonic acid into hydroxyl and epoxy derivatives.
Various xenobiotics induce the expression of different C. elegans cyp genes (Menzel et al.,
2001, 2005, 2007; Reichert and Menzel, 2005; Roh et al., 2006, 2007, 2010; Chakrapani et al.,
2008; Hasegawa et al., 2008; Roh and Choi, 2011; Wren et al., 2011; Laing et al., 2012;
Anbalagan et al., 2013; Peltonen et al., 2013) and the induction pattern is sometimes similar
between the closest CYP homologs in C. elegans and human (Chakrapani et al., 2008). C.
elegans CYPs have also been shown to metabolize xenobiotics such as PCB52 (Schäfer et al.,
2009). It appears that CYPs can both eliminate toxins and mediate their toxic effects, as the
silencing of cyp genes sometimes decreases and sometimes increases the sensitivity to toxic
compounds (Menzel et al., 2005, 2007; Ruaud and Bessereau, 2006; Cui et al, 2007; Kim and
Sun, 2007; Ayyadevara et al., 2009; Park et al., 2009; Leung et al., 2010; Roh et al., 2010; Roh
and Choi, 2011).
2.2.4.1 C. elegans CYP-35A subfamily
Members of the C. elegans cyp-35A subfamily are induced by a wide range of xenobiotics
(Menzel et al., 2001, 2005, 2007; Kwon et al., 2004; Reichert and Menzel, 2005; Roh et al.
2006, 2007, 2010; Chakrapani et al., 2008; Roh and Choi, 2011; Peltonen et al., 2013)
suggesting that they are involved in xenobiotic response. The CYP-35A family members
may also be targets for the toxicity of PCB52 that induces them as the RNAi knockdown of
cyp-35A1, cyp-35A3, cyp-35A5, and cyp-35C1 in  a cyp-35A2/cyp-35A4 double  mutant
background makes the nematodes more resistant to its reproductive toxicity (Menzel et al.,
2005). Also the silencing of cyp-35A2 makes the nematodes more resistant to the toxicity of
fenitrothion (Roh and Choi, 2011) or nanoparticles (Roh et al., 2010). Although members of
the cyp-35A subfamily  have putative  XRE sites  in  their  5’  flanking sequences  they are  are
not  regulated by AHR-1 as  they are  expressed and induced by xenobiotics  in ahr-1(ju145)
mutants in similar levels as in wild-type nematodes (Menzel et al., 2005).
RNAi studies indicate that cyp-35A2, 3, 4 and 5 are required for normal fat accumulation
(Ashrafi et al., 2003; Menzel et al., 2007). Moreover, PCB increases fat accumulation in wild-
type but  not  in cyp-35A subfamily  mutants  and this  may be  one of  the  mechanisms of  its
toxicity  (Menzel  et  al.,  2007).  The cyp-35A2 and cyp-35A3 genes are expressed in the
intestine which is a major location of fat stores. cyp-35A2, cyp-35A3 and cyp-35A4 may also
play a part in dauer formation pathways as their silencing with RNAi leads to increased
dauer formation (Jensen et al., 2010) and they are under-expressed in dauer-constitutive daf-
2 mutants (McElwee et al., 2003; Murphy et al., 2003).
2.3 CAENORHABDITIS ELEGANS (C. ELEGANS)
Caenorhabditis elegans (C. elegans) is an about 1 mm long nematode widely used in research.
Genome  comparisons  show  that  molecular  and  cellular  pathways  found  in C. elegans are
generally strongly conserved in higher organisms including human (Shaye and Greenwald,
2011). As a simple multicellular organism, C. elegans is especially well-suited to the study of
gene functions and molecular and cellular pathways involving intercellular interactions of
multiple cells. The nematode is also partially transparent which makes it good for live
imaging experiments. In this thesis, C. elegans has been used in the study of gene function in
e.g. the metabolism of fatty acids. Fat metabolism in C. elegans resembles that in mammals
with some exceptions. The following subsections will review C. elegans as a research model
especially in genetics, as well as lipid homeostasis and a class of lipid signaling molecules
called endocannabinoids in the nematode.
2.3.1 Basic biology of C. elegans
C. elegans consists of differentiated organs and tissues such as cuticle, hypodermis, muscles,
nervous system, gonad and intestine. It is not parasitic like many other nematodes but
naturally lives free in the soil in many parts of the world and feeds on micro-organisms. In
the laboratory C. elegans is usually grown in room temperature on nematode growth
medium  agar  plates  and  fed  with  bacteria.  One  commonly  used  food  source  is  the  OP50
strain of Escherichia coli (E. coli) that is auxotrophic for uracil and grows only in thin layers
on nematode growth medium allowing the nematodes to grow, move, mate and be
observed easily. Larger amounts of nematodes can be grown on plates or liquid media
containing more nutrients and better growing bacteria such as the NA22 strain of E. coli. C.
elegans also  survives  freezing  at  -70°C  and  can  thus  be  stored  for  later  use.  As  an
invertebrate, it typically does not require legal permits for its use in research.
There  are  two  sexes  in C. elegans:  hermaphrodite  with  sex  chromosomes  XX  and  male
with one X chromosome. Hermaphrodites produce both oocytes and sperm and fertilize
themselves but not each other. In self-fertilization, hermaphrodite progeny are about 500
times more frequent than males that arise spontaneously through an X-chromosome
nondisjunction during meiosis. However, there are “high incidence of males” (him) mutant
strains and the frequency of males can also be increased by incubating hermaphrodites at
30°C for 6 h and then allowing them to self-fertilize at 20°C. When males are mated with
hermaphrodites the oocytes are preferentially fertilized with the male’s sperm and an equal
amount of hermaphrodite and male progeny are produced. C. elegans clones established in
the laboratory are genetically uniform (Brenner, 1974). Self-fertilization also enables the
reproduction  of  mutants  with  severe  behavioral  or  morphological  defects  that  prevent
mating.
The hermaphrodite lays eggs that hatch and develop through four larval stages, L1 to L4,
each of which ends with molting. Each individual goes through the same cell divisions and
apoptoses during embryonic and larval development finally resulting in 959 somatic cells
in the adult hermaphrodite and 1031 in the adult male (Sulston et al., 1983). In case of
limited food source, high population density, or high temperature the L2 larva may
develop into an additional long-living larval stage, i.e. dauer larva, in which the living
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functions are slowed down. The dauer larva can again develop into an L4 larva and adult.
Normally the cycle from a newly laid egg to fertile adulthood takes about 2.5 days at 20°C
and the development rate is highly dependent on temperature. One hermaphrodite has
about 300 progeny through self-fertilization during its fertile period that last about 4 days.
If the hermaphrodite mates with males the total number of progeny may be more than
1000. The entire life span of C. elegans is about 18 to 20 days at 20°C. The short reproductive
cycle and life span make C. elegans well suited for studies that require assessment over an
entire life span or several generations.
2.3.2 C. elegans genetics, genomics and transcriptomics
The use of C. elegans as a research organism gained momentum in the 1960’s as Sydney
Brenner saw its potential as a small, simple, rapidly propagating yet multicellular model
organism for studying cellular development. He described its culturing and genetics
methods in his classical article (Brenner, 1974) in which also about 100 genes that affect
behavior or morphology were characterized.
In  the  traditional  genetic  experiments  in C. elegans,  gene  function  is  studied  by
identifying  and  isolating  loss-of-function  mutants  (reviewed  by  Kutscher  and  Shamam,
2014). In a forward genetics approach, mutations are induced randomly to the genome and
phenotypes are scored before detecting the mutations causing them. Random mutations
can be induced using a chemical mutagen, irradiation or insertion of transposons. In
reverse  genetics,  mutations  are  identified  before  proceeding  to  phenotype  assays.  This
approach can also start with random mutagenesis followed by screening for mutations e.g.
with  PCR.  Targeted  knockout  of  specific  genes  was  initially  not  possible  in C. elegans
because homologous recombination via DNA injection to oocyte nuclei widely used in
mammals is ineffective in the nematode. However, there are recently developed techniques
for targeted gene deletion such as MosDEL (Frøkjaer-Jensen et al., 2010) and MosTIC
(Robert and Bessereau, 2007) that utilize transposons, as well as systems based on zinc
finger- or transcription activator-like effector nucleases (Wood et al., 2011) or the bacterial
CRISPR-Cas9 endonuclease (Friedland et al., 2013). Also a technique using bombardment
with DNA-coated gold particles (Berezikov et al., 2004) has been developed but not widely
used. Mutant strains can be purchased from the Caenorhabditis Genetics Center.
A very feasible technique to silence specific target genes in C. elegans is RNA interference
(RNAi) in which double-stranded RNA (dsRNA) leads to degradation of a target mRNA or
blocks its translation (Fire et al., 1998). RNAi is systemic in C. elegans and can be induced by
injecting, soaking or feeding the dsRNA to the nematodes (Tabara et al., 1998; Timmons
and Fire, 1998). There are dsRNA libraries that represent a large fraction of all C. elegans
genes and RNAi screens have been performed genome-wide to detect genes involved in
specific phenotypes (reviewed by Lee et al., 2004; Kaletta and Hengartner, 2006). The
disadvantage of RNAi is that it does not always silence the gene completely and some cell
types, especially neurons, are resistant to it (Timmons et al., 2001).
Another  way to  study gene function is  transgenesis  that  is  relatively  easy in C. elegans.
Transgene expression can be directed to cells of interest using cell type-specific promoters.
The traditional method is to inject the transgene to the gonad in a vector such as a plasmid
(Stinchcomb et al., 1985; reviewed by Kadandale et al., 2009; Rieckher et al., 2009). To easily
detect transgenenic animals, the transgene is often co-injected with a marker gene such as
rol-6 that causes abnormal movement or production of green fluorescent protein (GFP). The
injected DNA is taken into oocyte nuclei where it replicates independently as an
extrachromosomal array that is transmitted unevenly to progeny (Mello et al., 1991). To
produce stable Mendelian inheritance of the transgene it has to be integrated into the
genome  by  e.g.  gamma  or  X  ray  irradiation.  There  are  also  new  techniques  that  produce
integrated transgenic lines that utilize microparticle bombardment (Praitis et al., 2001),
transposons (Frøkjaer-Jensen et al., 2008) or the CRISPR-Cas9 system (Chen et al., 2013;
Dickinson et al., 2013). Transgenesis can be used e.g. to model diseases by over-expressing a
disease-related gene (Kaletta and Hengartner, 2006), to rescue the function of a mutated
gene in specific cells or to visualize the anatomic expression pattern of a gene of interest by
combining its promoter to GFP (Chalfie et al., 1994; Dupuy et al., 2004).
C. elegans was the first multicellular organism with its entire genome sequenced (The C.
elegans Sequencing Consortium, 1998). The relatively small genome of about 100 Mb is
organized in six chromosomes including the X chromosome. C. elegans is predicted to have
about 20500 protein-coding genes (WormBase, 2011). For comparison, the human genome is
many times larger in size (3000 Mb) but the number of protein-coding genes (20700) is close
to that in C. elegans (The ENCODE Project Consortium, 2012). However, the human genes
produce a larger variety of mRNAs and proteins. Human orthologs have been identified for
~38 % of C. elegans genes (Shaye and Greenwald, 2011). Estimates about the proportion of
human genes that have a C. elegans ortholog vary from 60 to 80 % but are not up to date
(reviewed by Kaletta and Hengartner, 2006). An unusual feature of nematode genomes is
that they contain polycistronic clusters of genes that are expressed under the control of one
regulatory signal, resembling bacterial operons (Blumenthal and Gleason, 2003). About 15
% of C. elegans genes are estimated to be in such polycistronic clusters but these are
typically genes that do not need to be regulated individually.
C. elegans has also been used in transcriptomics (Reisner et al., 2005). The early
completion of the C. elegans genome project allowed the production of C. elegans gene
expression  profiling  microarrays.  Also  other  methods  such  as  serial  analysis  of  gene
expression (SAGE) and more recently RNA-seq have been used. The main limitation of C.
elegans in transcriptomics is that because of its small size, cell- or tissue-specific gene
expression is difficult to assess. Typically, RNA for the experiment is derived from
populations of whole animals. Specific cell types can be harvested by expressing GFP in
them and subsequently isolating them with fluorescence-activated cell sorting (Christensen
et al., 2002). Another technique is to co-immunoprecipitate poly(A)-RNA with a poly(A)
binding protein expressed in specific cells (Roy et al., 2002). The use of single cells requires
RNA amplification for which sophisticated methods have been developed (Hashimshony et
al., 2012).
2.3.3 Lipid storage and fatty acids in C. elegans
C. elegans can also be used as a model to study lipids. It differs from mammals on a cellular
level in that it does not have adipocytes. Instead, fat is stored as triacylglyceroles in
intestinal lysosome-related organelles (Hermann et al., 2005) and in lipid droplets found in
intestinal and epidermal skin-like cells (O’Rourke et al., 2009). Fat stores can be visualized
with different methods such as Sudan black (Kimura et al., 1997, Ogg et al., 1997), Nile Red
(Ashrafi et al., 2003; McKay et al., 2003), Oil-Red-O (O’Rourke et al., 2009; Soukas et al.,
2009), boron-dipyrromethene (BODIPY) fluorescently labeled fatty acids (Mak et al., 2006;
Klapper et al., 2011) or coherent anti-Stokes Raman scattering (CARS) microscopy (Hellerer
et al., 2007).
The fat stores are dynamically regulated and major regulatory pathways are conserved
between C. elegans and human (reviewed by Jones and Ashrafi, 2009; Mullaney and Ashrafi,
2009). Fatty acids are taken up into the stores by diffusion and active transport, released by
lipases and used for energy in a series of Ά-oxidation reactions (Zhang et al., 2010). An
RNAi screen by Ashrafi et al. (2003) identified hundreds of genes that increase or reduce fat
content in C. elegans. C. elegans responds to environmental signals such as availability of
food. Neuroendocrine signaling systems regulate both behaviors and peripheral lipid
metabolism in response to sensory cues. Such neuroendocrine systems include e.g. insulin
(Kimura et al.; 1997, Ogg et al., 1997), serotonin (Srinivasan et al., 2008), TGF-Ά (Greer et al.,
2008) and Tubby signaling (Mak et al., 2006). Other factors function directly at the sites of
fat storage and can sometimes feed back to the nervous system. These include e.g. several
transcription factors that regulate the expression of lipid metabolism genes (reviewed by
Brey et al., 2009).
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Several classes of lipids contain fatty acids. Fatty acids vary in length and in the number
and position of double bonds. In fatty acid nomenclature (Davidson and Cantrill, 1985), the
first number refers to the number of carbons and the second to the number of double
bonds. Saturated fatty acids do not contain double bonds, monounsaturated fatty acids
contain  one  and  polyunsaturated  fatty  acids  (PUFAs)  more  than  one  double  bond.  The
denotion “n3” means that starting from the methyl end of the fatty acid chain the closest
double bond is between the 3rd and 4th carbons, whereas in “n6” fatty acids it is between the
6th and 7th carbons. n3 can also be written as Ν-3 (omega-3).
C. elegans takes  up  fatty  acids  from  diet  and  synthesizes  them de novo (Perez  and  Van
Gilst, 2008). According to Zhang et al. (2010), the food source OP50 E. coli contains mainly
palmitic (16:0) and stearic (18:0) acids. Palmitic acid can also be synthesized de novo from
acetyl-CoA by acetyl-CoA carboxylase and fatty acid synthase (Rappleye et al., 2003).
Unlike humans, C. elegans can create the long-chain PUFAs arachidonic acid (20:4n6) and
eicosapentaenoic acid (20:5n3) from palmitic acid by modifying the fatty acids with
desaturase and elongase enzymes that are sequentially named FAT-1 to 7 and ELO-1 to 8,
respectively (Watts and Browse, 2002). Figure 1 does not show all  fatty acids in C. elegans
but focuses on the steps required for the generation of arachidonic (20:4n6) and
eicosapentaenoic (20:5n3) acids.
Figure 1. Synthesis of long-chain polyunsaturated fatty acids from fatty acid precursors by fatty
acid desaturase and elongase enzymes in C. elegans (modified from Watts and Browse, 2002)
Palmitic acid (16:0) is elongated by ELO-2 to obtain stearic acid (18:0). The elo-2 gene
expression  is  required  for  e.g.  normal  growth,  reproduction  and  biological  rhythms
(Kniazeva et al., 2003). Palmitic acid (16:0) can also be desaturated into palmitoleic acid
(16:1n7) by FAT-5 (Watts and Browse, 2000). Stearic acid (18:0) is desaturated into oleic acid
(18:1n9) by the desaturases FAT-5, FAT-6 and FAT-7 that are functionally redundant. While
single mutations of fat-5, fat-6 and fat-7 genes appear normal with only subtle alterations in
fatty acid composition, the triple mutation is lethal (Brock et al., 2006).
Linoleic acid (18:2n6) is a precursor for n6 PUFAs and ΅-linoleic acid (18:3n3) for n3
PUFAs. While humans need to obtain these fatty acids from diet, C. elegans can synthesize
them. Linoleic acid (18:2n6) is synthesized from oleic acid (18:2n6) by the desaturase FAT-2,
and ΅-linoleic acid (18:3n6) from linoleic acid (18:2n6) by FAT-1. FAT-1 can also synthesize
other n3 PUFAs from n6 percursors. fat-2 mutants display slow growth, abnormal body
shape, sluggish movement, cuticle defects and reduced brood sizes. fat-1 mutants lack n3
PUFAs but are apparently normal in growth, morphology, reproduction and movement.
The C. elegans fat-1 gene has been transgenically expressed in mice, cattle and pig (Kang et
al., 2004; Guo et al., 2011; Zhang et al., 2012). The decreased n6/n3 fatty acid ratio in the
transgenic mice has been shown to e.g. have anti-inflammatory effects and protect against
tumorigenesis and pathological angiogenesis (reviewed by Kang, 2007).
Linoleic (18:2n6) and ΅-linoleic (18:3n3) acids are further desaturated into ·-linoleic
(18:3n6) and stearidonic (18:4n3) acids, respectively, by the desaturase FAT-3 (Watts and
Browse, 2002). fat-3 mutation causes embryonic lethality, abnormal morphology, small
brood sizes and slow growth and movement (Watts et al., 2003). The ·-linoleic (18:3n6) and
stearidonic (18:4n3) acids are elongated to dihomo-·-linoleic (20:3n6) and eicosatetraenoic
(20:4n3) acids, respectively, by the elongase ELO-1 and possibly also ELO-2. While elo-1
mutants appear normal, suppression of elo-2 in the elo-1 mutants causes nearly total
depletion of 20-carbon polyunsaturated fatty acids, abnormal body morphology, small
brood sizes and death of some progeny in the first larval stage (Kniazeva et al., 2003). The
final step of arachidonic and eicosapentaenoic acid synthesis is catalyzed by FAT-4. fat-4
mutants appear normal despite the lack of these fatty acids. fat-1; fat-4 double mutants have
small abnormalities such as defects in TRPV receptor-mediated olfaction (Kahn-Kirby et al.,
2004) or sensitivity to dihomo-·-linoleic acid-induced sterility (Watts and Browse, 2006).
Unlike human, C. elegans cannot synthesize 22-carbon or longer fatty acids from 20:4n6 and
20:5n3 (Watts and Browse, 2002).
In addition, C. elegans synthesizes other kinds of fatty acids such as monomethyl
branched fatty acids that are important for its larval development (Kniazeva et al., 2004).
The fatty acid desaturase and elongase genes are regulated by several transcription factors
such as the nuclear hormone receptor NHR-49 (Van Gilst et al., 2005a, b) that functions
together with the Mediator subunit MDT-15 (Taubert et al., 2006), as well as by NHR-80
(Brock et al., 2006) or the sterol regulatory element binding protein SBP-1 (Kamath et al.,
2003; Kniazeva et al., 2008) some of which control also other aspects of lipid homeostasis.
Defects seen in the nematodes lacking fatty acid desaturase or elongase enzymes show
the importance of the different fatty acids. Proportions of different fatty acids in membrane
phospholipids affect the structure of the membranes and several cellular functions
(reviewed by Spector and Yorek, 1985; Ibarguren et al., 2014). The normal appearance of fat-
1 and fat-4 mutants at least in standard laboratory conditions is somewhat surprising
considering the importance of arachidonic acid and n3 fatty acids in mammals.
2.3.4 Endocannabinoid system in C. elegans
The main psychoactive compound in cannabis, ̇(9)-tetrahydrocannabinol, acts via CB1-
type cannabinoid receptors in the mammalian brain (Devane et al., 1988; Matsuda et al.,
1990). Endogenous ligands for these receptors were named endocannabinoids. The first
found endocannabinoids were N-arachidonoylethanolamine (a.k.a. anandamide or AEA,
Devane et al., 1992) and 2-arachidonoylglycerol (2-AG, Mechoulam et al., 1995). The
endocannabinoid system consists of the endocannabinoids themselves, their receptors and
enzymes for their synthesis and degradation as well as other factors regulating their actions
or transport. C. elegans has endocannabinoids but other components of its endocannabinoid
system are not yet well defined.
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Endocannabinoids have a fatty acyl group linked to another chemical group that
depends on the type of the endocannabinoid. The chemical group can be an ethanolamine
in N- or O-acylethanolamines (NAEs and OAEs, Hanus et al., 1993; Porter et al., 2002;
Hansen and Diep, 2009), glycerol in monoacylglycerols (Hanus et al., 2001) or dopamine in
N-acyldopamines (Huang et al., 2002; Chu et al., 2003). AEA is a NAE and 2-AG a
monoacylglycerol,  and  both  have  their  fatty  acyl  moieties  derived  from  arachidonic  acid.
There are likely also many other types of endocannabinoids that have not yet been
identified. In C. elegans, several endocannabinoids have been identified including AEA, 2-
AG, N-palmitoleoyl ethanolamine, N-eicosapentaenoyl ethanolamine, N-lineoyl
ethanolamine, N-oleoyl ethanolamine and N-palmitoyl ethanolamine (Lehtonen et al., 2008,
2011; Lucanic et al., 2011).
In mammals, endocannabinoids are derived from membrane phospholipids through
several routes. The most studied NAE synthesis pathway involves a hydrolysis by N-
acylphosphatidylethanolamine phospholipase D (NAPE-PLD, Okamoto et al., 2004) but
there are also other NAE synthesis pathways not dependent on NAPE-PLD (reviewed by
Hansen and Diep, 2009). The C. elegans homolog  of  NAPE-PLD  named  NAPE-1  is  not
necessary for the synthesis of NAEs (Lucanic et al., 2011) but this may be due to the
presence of alternative NAE synthesis routes as in mammals (Leung et al., 2006). In
mammals 2-AG is made by diacylglycerol lipase (DAGL, Bisogno et al., 2003). Its homolog
in C. elegans is F42G9.6 whose function is not known (McPartland et al., 2006).
AEA and other NAE-type endocannabinoids are catabolized mainly by fatty acid amide
hydrolase (FAAH, Schmid et al., 1985; Cravatt et al., 1996). The C. elegans FAAH ortholog
FAAH-1  appears  to  degrade  NAEs  since  its  silencing  elevates  and  transgenic  over-
expression reduces NAE levels (Lucanic et al., 2011). In mammals, 2-AG is mainly
catabolized by monoacylglycerol lipase (MAGL, Dinh et al., 2002) although other enzymes
such as cyclo-oxygenase 2 (COX2, Yu et al., 1997a), lipoxygenases and CYPs have also been
shown to metabolize endocannabinoids (reviewed by Ueda et al., 2010). The closest
homologs for MAGL and COX2 are F01D5.7 and C46A5.4, respectively, but it is not known
whether they degrade 2-AG or not (McPartland et al., 2006). It is also possible that C. elegans
CYPs metabolize endocannabinoids.
Mammalian receptors for endocannabinoids include the CB1, CB2 (Munro et al., 1993),
the transient receptor potential vanilloid type 1 (TRPV1, Zygmunt et al., 1999), the G
protein-coupled receptors GPR-55 (Baker et al., 2005) and GPR-119 (Overton et al., 2006)
and peroxisome proliferator-activated receptors (PPARs) of subtypes ΅ and · (Fu et al.,
2003; Bouaboula et al., 2005; Lo Verme et al., 2005; Rockwell et al., 2006). C. elegans has
proteins with some homology to the CB1/CB2, TRPV1 and GPR-55 receptors (NPR-19,
OSM-9  and  NPR-9,  respectively)  but  they  are  not  very  likely  to  function  as  cannabinoid
receptors (McPartland et al., 2006). The CB1 homolog NPR-19 lacks many of the amino acid
residues required for ligand binding or signal transduction (McPartland and Glass, 2001,
2003). The C. elegans homolog of TRPV1, OSM-9, appears insensitive to the exogenous
TRPV1 ligand capsaicin (Tobin et al., 2002). Jordt and Julius (2002) identified amino acid
residues  that  determine the  sensitivity  of  the  TRPV1 receptor  to  both capsaicin  and AEA.
The C. elegans OSM-9 has a substitution at T550 amino acid residue as do some other
capsaicin-insensitive TRPV receptors (McPartland et al., 2006) suggesting that OSM-9 is not
likely activated by AEA.
Although endocannabinoid receptors have not been identified in C. elegans,
endocannabinoids do have functions in the nematode. Lucanic et al. (2011) demonstrated
with a series of experiments that NAE-type endocannabinoids mediate the signal of
nutrient availability which prevents dauer formation and dietary restriction-related lifespan
extension in C. elegans. First they showed that NAEs are required for normal growth rate. In
the presence of abundant food NAEs reach their highest levels in L2 stage during which the
nematode commits to reproductive development instead of entering into dauer stage. In
dauer-constitutive daf-2 mutants, NAE levels are lower than in wild-type after the decision
to enter into dauer stage. Treatment with the major NAE, N-eicosapentaenoylethanolamine,
prevents dauer formation in daf-2 and other dauer-constitutive mutants. Moreover, NAEs
are also low in starved animals and rise after refeeding. Dietary restriction increases
lifespan (Klass, 1977), and the lowering of NAE levels by transgenic over-expression of faah-
1 has a similar effect. The lowering of NAE levels does not have an additive effect on
lifespan in dietary restriction conditions suggesting that NAE reduction and dietary
restriction are mechanistically equivalent. Correspondingly, EPEA treatment dramatically
reduces the lifespan extension in dietary restriction. Another,  different function of AEA is
that it inhibits axon regeneration in mature C. elegans neurons  through  the  Go΅ receptor
subunit GOA-1 (Pastuhov et al., 2012).
The  endocannabinoid  system  is  related  to  energy  metabolism  also  in  mammals.  Over-
activity of the endocannabinoid system has been associated with obesity by acting through
the cannabinoid receptor CB1 in several tissues such as brain, adipose tissue, liver, pancreas
and skeletal muscle (Matias and Di Marzo, 2007; Maccarrone et al., 2010). CB1 antagonists
alleviate obesity and improve the plasma lipid profile and insulin sensitivity in obese mice
and rats (Cota et al., 2009; Jourdan et al., 2010). In mammals the endocannabinoid system
has also many other functions playing a modulatory role in e.g. immune response,
cognition, emotion, perception, behavioral reinforcement, motor coordination, body
temperature, wake/sleep cycle, bone formation and resorption, and various aspects of
hormonal control, pain, inflammation and reproductive functions (Wang et al., 2006; Fine
and Rosenfeld, 2013; Robson, 2013).
2.4 TRANSCRIPTOMICS
The central dogma of molecular biology is that DNA directs the synthesis of RNA which
then directs the assembly of proteins. Proteins present in a particular cell type determine its
structure  and  functions  by  serving  as  structural  proteins  or  enzymes  that  catalyze  the
synthesis  of  other  classes  of  biological  molecules.  The  process  of  decoding  the  genetic
information into a functional gene product is called gene expression.
Gene expression must be regulated to determine which proteins are found in each cell at
a given time point. This regulation generates the variety of cell types with different
appearences and functions in an individual with the same genome in all its cells and makes
it adaptable to environmental signals. Gene expression is regulated in several steps, such as
transcription, mRNA processing and stability, translation and protein modification.
As genome sequences are known for more and more organisms, current research focuses
on understanding the dynamic functions of the genomes. One approach is transcriptomics
i.e. the study of transcriptomes that can also be called gene expression profiling.
Transcriptome refers to the complete set of transcripts and their quantity in a cell for a
specific developmental stage and physiological condition (Wang et al., 2009). Gene
expression profiling experiments typically compare trancriptomes between e.g. different
cell types or developmental stages, or study the effect of a disease or treatment, while
advanced methods also allow the finding of new transcripts.
The transcriptome is greatly influenced by factors that regulate transcription initiation,
including also AHR. The following subsections give a quick overview on the regulation of
transcription initiation, as well as on some of the methods used in transcriptomics and
initiatives to facilitate the sharing of datasets generated by the methods.
2.4.1 Regulation of transcription initiation
Transcription of eukaryotic protein-coding genes is catalyzed by RNA polymerase II. Other
factors necessary for transcription initiation include general transcription factors such as
TFIIA, TFIIB, TFIID, TFIIE, TFIIF and TFIIH some of which consist of several subunits, and
the Mediator complex. These proteins form a transcription preinitiation complex and bind
co-operatively to DNA regions called core promoters located near the transcription start
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site (Maston et al., 2006). General transcription factors have many functions including
promoter recognition, interaction with regulatory factors, DNA unwinding and RNA
polymerase II regulation (Sikorski and Buratowski, 2009; Grünberg and Hahn, 2013).
The  general  transcription  machinery  drives  only  low  levels  of  gene  expression.
Transcription is greatly activated or repressed by another class of transcription factors that
bind to specific DNA sequences further away from the transcription start site (Maston et al.,
2006). The human genome is predicted to have over a thousand such transcription factors
and  they  can  be  classified  based  on  the  structure  of  their  DNA  binding  domains
(Vaquerizas et al., 2009). For example, AHR belongs to the bHLH class. Transcription factor
binding sites in DNA are short (~6-12 bp) consensus sequences. Genes have regulatory
elements that contain binding sites for several transcription factors acting synergistically
(Maston et al., 2006). Regions up to a few hundred bp upstream of the core promoter are
called proximal promoter elements, whereas enhancers and silencers can be located tens of
kilobases upstream or downstream of the transcription start site and be brought close to the
core promoter by DNA looping.
The specific transcription factors can recruit coactivators and corepressors that
participate in the regulation of transcription without binding to DNA sequence-specifically
(Maston et al., 2006). Several coactivators and corepressors can modify the structure of
chromatin i.e. the complex formed of DNA and proteins, primarily histones. Some
coactivators and corepressors covalently add chemical groups to histones or remove them
(reviewed by Rosenfeld et al., 2006). Histone modifications include acetylations,
phosphorylations, methylations, ubiquitylations, ribosylations and sumoylations. The
activating or repressing function of these modifications depends on the chemical group, the
amino acid residue modified and the context of other modifications (Berger, 2007). Histone
modifications can directly alter chromatin structure or recruit effector proteins. Another
class of coactivators are ATP-dependent chromatin remodelers that disassociate stretches of
DNA from histones in various ways exposing binding sites for proteins of the transcription
machinery (Clapier and Cairns, 2009; Tang et al., 2010). Activator transcription factors and
coactivators can also facilitate the formation of the preinitiation complex and subsequent
steps in transcription (reviewed by Lee and Young, 2000).
Repressor transcription factors can inhibit activation in many ways (Latchman, 1996; Lee
and Young, 2000). They can block the binding of activator transcription factors by
competing for binding sites, by binding to the activator transcription factor itself or by
recruiting corepressors that modify chromatin. Repressor transcription factors may also
interact with DNA-bound activator transcription factors inhibiting their function. They can
also inhibit the assembly or activation of the preinitiation complex by binding directly to its
components or upstream silencer elements in DNA. One transcription factor can have both
activator and repressor roles depending on the presence of other factors.
While some transcription factors are constitutively active or regulated only on the level
of their own expression, other transcription factors are post-translationally activated by a
signal (Brivanlou and Darnell, 2002). The signal can be e.g. an extracellular ligand such as a
steroid hormone or another lipid-soluble compound that enters the cell. Mammalian AHR
is an example of a transcription factor activated this way. For some transcription factors, the
activating ligand is intracellular. Also peptide hormones binding to cell surface receptors
can activate transcription factors via intracellular signal transduction cascades. In addition,
signal transduction pathways can regulate the composition and function of coactivator
complexes (Rosenfeld et al., 2006).
2.4.2 Transcriptomics methods
The field of transcriptomics utilizes high-throughput methods that can measure thousands
of transcripts simultaneously rather than a gene-by-gene approach. In the 1980’s the first
methods assaying large numbers of mRNA species included differential hybridization
(reviewed by Liang and Pardee, 2003) and subtractive hybridization (Zimmermann et al.,
1980). These methods were followed by differential display PCR (Liang and Pardee, 1992)
and serial analysis of gene expression (SAGE, Velculescu et al., 1995). Microarray
technology started becoming popular in gene expression profiling in the late 1990’s likely
because it is very high-throughput, simple for the end-user and cheaper than the other
methods. Newer methods based on sequencing have been developed, including massively
parallel signature sequencing (MPSS, Brenner et al., 2000), cap analysis of gene expression
(CAGE, Shiraki et al., 2003) and newer variants of SAGE (Saha et al., 2002; Gowda et al.,
2004; Matsumura et al., 2005). However, only the rather recent method high throughput
RNA sequencing (RNA-seq) that utilizes next-generation sequencing technologies is
challenging microarrays (Wang et al., 2009). Microarrays and RNA-seq are overviewed in
the following subsections.
2.4.2.1 Microarrays in transcriptomics
Gene expression profiling microarrays consist of a series of DNA targets immobilized onto
a solid surface in an ordered fashion so that the location of each target can be referenced.
Their use in transcriptomics is based on hybridization of labeled complementary DNA or
RNA probes derived from a sample.
There are many kinds of microarrays depending on the manufacturer. In the early DNA
microarrays (Schena et al., 1995, 1996), the targets were hundreds of nucleotides long cDNA
fragments spotted onto the surface. Several research groups and microarray core facilities
have made their own custom microarrays this way. Another type of microarray consists of
oligonucleotides (25-60 nt) that can be synthesized directly onto the platform, allowing a
higher target density (Lockhart et al., 1996). In a newer technology, oligonucleotide targets
are attached to beads that then assemble into arrays (Kuhn et al., 2004). The two latter types
of microarrays can only be obtained from commercial sources.
In a microarray experiment, the RNA molecules isolated from a tissue of interest are
converted to fluorescence-labeled cDNA or complementary RNA probes. The probes
hybridize specifically to their complementary targets on the array and are detected by laser
confocal microscopy. Signal intesities on the array are assumed proportional to the
abundance of the corresponding RNA species in the original sample (Mirnics and Pevsner,
2004). The signals are quantified, filtered and normalized to remove non-biological
variation between and within arrays (Wolkenhauer et al., 2002; Saviozzi and Calogero,
2003). Differentially expressed genes between conditions are determined from the
normalized values using relative expression levels and statistical tests.
Although  DNA  microarrays  can  assay  a  very  large  number  of  transcripts  in  a  single
experiment, they also have limitations. Firstly, they require knowledge on the sequence to
be assayed. Obtaining genome sequences is getting easier as genome projects are being
completed for more and more organisms. However, the reliance on existing sequence data
makes it difficult to find new transcripts. For this kind of purposes there are tiling arrays in
which areas of the genome are represented at a high density (Kapranov et al., 2002) but
they are expensive and have only a limited ability to distinguish between different isoforms
(Wang et al., 2009). Another limitation of DNA microarrays is that they do not measure
absolute levels of expression and comparing expression levels between different
experiments is problematic. In addition, there are technical issues such as high background
noise and saturation of signal that prevent the detection of transcripts with very low or
high abundances.
2.4.2.2 RNA-seq
RNA-seq is a trascriptomics application that uses next-generation sequencing technologies
(Wang et al., 2009). Next-generation sequencing refers to recent sequencing technologies
that are dramatically faster and more affordable than the traditional Sanger sequencing
(Sanger et al., 1977). The techniques are variable and constantly developing. The most used
technologies in RNA-seq have so far been Illumina, Roche/454 and SOLiD.
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In an RNA-seq experiment, a library of cDNAs is generated from the isolated RNA and
the cDNAs are then sequenced to obtain short sequence reads (Wang et al., 2009). The
details of library preparation, sequencing and intermediate steps vary between the different
technologies. In all current platforms, mRNA or the reverse-transcribed cDNA needs to be
fragmented into smaller pieces (200-500 nt). Small non-coding RNAs do not need
fragmentation. Typically adapter sequences are ligated to both ends of the cDNAs and
there can also be amplification steps before sequencing. The cDNA fragments are
sequenced from one or both ends and the reads obtained are 30-400 nt in length depending
on the sequencing technology. In data analysis, the sequence reads are either aligned to an
existing reference genome or assembled de novo to  identify  the  transcripts  and  their
abundancies.
RNA-seq has several advantages compared to microarrays (Wang et al., 2009). RNA-seq
does not require prior knowledge about the transcripts to be sequenced. Even a reference
genome is not necessary although it can be utilized in read assembly. RNA-seq reveals the
precise boundaries of transcripts as well as single-base variations. Thus, novel transcripts
such as  different  isoforms or  entirely  new RNA classes  can be  found.  RNA-seq expresses
the amounts of different transcripts as absolute values, not as relative amounts. In addition,
RNA-seq can detect transcripts expressed in very low and very high levels due to low
background noise and no saturation of signal. Also the amount of RNA sample required is
smaller compared to microarray. The older sequencing-based methods SAGE, CAGE and
MPSS  differ  from  RNA-seq  in  that  they  analyze  only  a  part  of  the  transcript  and  cannot
distinguish between all isoforms. RNA-seq does not have this limitation as the short
sequence reads generated should span the whole length of the transcript. What also makes
RNA-seq more popular than the older sequencing-based methods is the significantly lower
price. The prices of microarrays and RNA-seq are comparable. At the moment RNA-seq is a
bit cheaper than tiling arrays while more old-fashioned microarrays are still cheaper than
RNA-seq.
RNA-seq also has some challenges (Wang et al., 2009). The manipulation steps during
the cDNA library construction, such as fragmentation and amplification, can cause bias.
The experiment produces massive amounts of data. In data analysis, reads that span exon
junctions or contain polyA have to be taken into account.
2.4.3 Transcriptomics data sharing and standards
Transcriptomics experiments produce large amounts of data. Public databases were started
in order to store microarray data and make it available to the whole research community in
an appropriate and usable format that would allow new data comparisons and the analysis
of existing results with new methods and tools. The most used gene expression databases
are Gene Expression Omnibus (GEO, Edgar et al., 2002) by National Center for
Biotechnology Information and ArrayExpress (Brazma et a., 2003) by the European
Bioinformatics Institute. Both databases accept array- and sequencing-based data. Another
major gene expression database, Center for Information Biology gene EXpression (CIBEX)
by the DNA DataBank of Japan (Ikeo et al., 2003), is currently being migrated to a new
system.
Since gene expression profiling data is dynamic and highly dependent on the conditions
in which it was generated it is necessary to record detailed description of how the
expression values were obtained. The Minimum Information About a Microarray
Experiment  (MIAME)  document  was  developed  by  the  Microarray  Gene  Expression
Database Society (MGED, now called Functional Genomics Data Society, FGED) to provide
a standard on what information to record and report (Brazma et al., 2001). Similar
guidelines have been developed for high-throughput sequencing data: Minimum
Information About a high-throughput SEQuencing Experiment (MINSEQE, Brazma, 2009).
The essential information to be presented according to both MIAME and MINSEQE include
the complete raw data, the final processed data, description of the samples and
experimental conditions, experimental design, and experimental and data processing
protocols (Functional Genomics Data Society, 2014). Although the information can be in
any format, standard data exchange formats have been developed to allow communication
of MIAME-supportive data between different data systems. Currently FGED recommends
the use of the standard format MAGE-TAB that is relatively simple and spreadsheet-based
(Rayner et al., 2006). Also an MGED Ontology has been developed to provide a controlled
vocabulary to describe a microarray experiment (Whetzel et al., 2006). The public
repositories GEO, ArrayExpress and CIBEX are designed to accept, hold and distribute
MIAME compliant data and several scientific journals (Functional Genomics Data Society,
2010) require submission of MIAME-compliant data to databases prior to publication.
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3 Aims of the study
While the roles of AHR and CYPs in toxicology are well established the whole range of
their physiological functions is not thoroughly understood. Most of the studies so far have
been performed in mice and rats but the knowledge on the functions of AHR and CYPs in
C. elegans is still very limited. Research in C. elegans can elucidate which functions of AHR
and CYPs are evolutionarily conserved, or result in finding novel functions not yet studied
in higher organisms. Progress in genomics has lead to the development of methods such as
microarrays that enable measuring entire transcriptomes. Therefore, the general aims of the
present study were to investigate the basic physiological roles of AHR and CYPs in C.
elegans using a combination of phenotyping, fatty acid profiling and transcriptomics
approaches, and follow the development of transcriptomics methods and their usage.
The more detailed aims of the study were to:
1. Derive gene expression profiling microarray usage statistics from neuroscience
publications in order to determine current trends and infer future directions in the
application of microarrays (I)
2.  Study the  physiological  function of  AHR in C. elegans, focusing on its possible roles in
neuronally controlled behaviors, development, regulation of fatty acid diversity and control
of gene expression (II and IV)
3. Study the physiological function of CYP-35A subfamily members in C. elegans, focusing
on  their  possible  roles  in  the  regulation  of  lipid  homeostasis  and  endocannabinoid  levels
(III)
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4 Materials and methods
The methods used in the original publications are summarized in Table 2.
Table 2. List of methods used in the publications I-IV.
Method Original publication
Systematic review on microarray studies I
C. elegans strains and their growth II, III, IV
Overall fatty acid compositions using Gas Chromatographic Mass
Spectrometry II, III
Gene expression using Quantitative Real-Time PCR (qRT-PCR) II, III, IV
Phenotype assays (larval development, egg laying, embryonic lethality,
movement, defecation, brood size) II
Gene expression profiling using microarrays II
Sequence alignments of human and C. elegans CYPs III
Fat content using Oil-Red-O staining III
Feeding of fatty acids in triglycerides to C. elegans III
Endocannabinoid levels using Liquid Chromatographic Mass Spectrometry III
Gene expression profiling using RNA-seq IV
Search for putative XRE sites IV
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5 Results and discussion
5.1 MICROARRAY STUDIES IN THE NEUROSCIENCES
Microarrays were a relatively new and rapidly growing technology in 2004. The field of
neuroscience had been thought to particularly benefit from it as nervous tissue is the most
transcriptionally complex system and brain disorders involve interaction of many genetics
factors (Mirnics and Pevsner, 2004). To determine overall usage statistics of microarrays in
the neurosciences, data was collected on laboratories, source tissues, study designs,
microarray platforms, analysis tools and availability of datasets from published literature.
5.1.1 Microarray field grew rapidly and was used in many types of studies
The literature search resulted in 2025 publications of which 502 fulfilled the criteria of being
original  gene  expression  profiling  microarray  studies  on  neural  or  glial  material  and
published in  peer-reviewed English language journals  (I,  Table  1).  Of  these,  448  could be
accessed. The first five microarray studies in the neurosciences had been published in 1999
and the number of studies had increased every year being 283 in 2004 (I, Figure 1A). In the
early years, the design and manufacture of microarray platforms for neuroscience
applications had likely been limited by the lack of sequence data from higher organisms,
while  the  completion  of  genome  projects  facilitated  the  growth  of  the  field.  The
geographical distribution of publications was international although highly weighted
towards the USA (I, Figure 1B).
The microarray articles represented different study types (I, Table 2). In many, disease
had been studied using either animal models or post-mortem tissue from human patients.
Fourty-four (44) different brain-related diseases had been studied using microarrays, most
of them only in one or two studies (I, Table 3).  The  most  studied  disease  was  ischemic
stroke (26 studies). Also age-related neurodegenerative diseases, mainly Alzheimer’s
disease and Parkinson’s disease, had been studied in several publications. There were also
many publications that could be classified as physiology studies. These had investigated
the effect of e.g. genetic manipulation, endogenous compound or development. Studies on
the  effect  of  an  exogenous  compound,  either  toxic  or  beneficial,  were  also  common.  In
addition, there were some publications that had studied the effect of mechanically or
chemically induced injury, infection or non-chemical treatment, or compared brain areas or
species. Some studies had to be classified in more than one category.
A quick search in  PubMed using the  same words as  in  Publication I indicates  that  the
number of neuroscience studies utilizing microarrays appears to have still grown reaching
the top value in 2011 after which it has slightly decreased (data not shown). The use of
RNA-seq is constantly growing (data not shown). It is not straightforward to compare the
numbers  of  publications  between  the  two  methods  as  the  use  of  synonyms  in  the  search
greatly influences the results. If only the words “microarray” or “RNA-seq” are used
microarray appears the more used method in neuroscience although the numbers have
been getting closer every year since the first RNA-seq neuroscience publication in 2008
(data not shown). In the future there may be a shift in the field towards RNA-seq. The early
neuroscience studies utilizing RNA-seq also tend to answer different scientific questions,
such as finding novel genes and isoforms, rather than being “traditional” gene expression
comparisons between conditions as microarray experiments typically are.
5.1.2 Source material
The coverage of different animal species in the studies was rather limited. Mouse and rat
studies constituted more than two thirds of all studies (I, Table 4). Studies utilizing human
tissues or cell lines made up approximately one fifth of the studies. Non-human primates
were used in 21 studies. There were also some rarer model organisms each used in 1 to 5
studies, including honey bee, fruit fly, Siberian hamster, cat, cattle, channel catfish, guinea
pig, planaria and rabbit. The use of other model organisms has likely been limited by the
lack of microarray platforms available. Microarrays for mouse, rat and human were readily
available from several sources. Non-human primates were studied using human
microarrays because of a high sequence similarity, but these animals are not grown
specifically for laboratory use. Also the focus on neuroscience may explain why most of the
species used were relatively large vertebrates.
No studies in C. elegans found in the literature search fulfilled the criteria of being
microarray studies on neuronal material because the nematodes are usually assayed as
whole animals instead of using only neurons. Microarrays have already long been available
for C. elegans, and Reisner et al. (2005) review 26 C. elegans microarray studies published
before 2005. A study by Link et al. (2003) was related to neuroscience as it involved an
Alheimer’s disease model. However, also in this publication the nematodes were profiled
as whole animals. Isolation of sufficient amounts of RNA from C. elegans neural tissue
requires isolation of cells, that is not easy, and amplification of RNA (or cDNA) that can
cause bias to the results. However, cell type-specific gene expression can be measured using
mRNA tagging (Roy et al., 2002) or primary cell cultures obtained from dissociated
embryos with fluorescence-activated cell sorting (FACS, Christensen et al., 2002). These
methods have been used after the time of the survey (I) to find genes whose expression is
enriched in neurons or specific neuron types (Colosimo et al., 2004; Cinar et al., 2005; Fox et
al., 2005; Kunitomo et al., 2005; Von Stetina et al., 2007; Takayama et al., 2009; Smith et al.,
2010; Spencer et al., 2011). The literature search (I) also missed an earlier study that
compared gene expression profiles of isolated wild-type and mutant touch receptor
neurons in C. elegans (Zhang et al., 2002).
In more than half of the studies (305) a discrete brain area was used, as different brain
areas can vary greatly in their gene expression and diseases or functions involve specific
brain areas. Microarray datasets have been created from a very wide range of brain regions.
There were especially many studies on cerebral cortex and brain regions affected in
common neurological disorders. For example, CA1 region of the hippocampus, amygdala,
cingulate cortex and superior temporal gyrus that are associated with Alzheimer’s disease
were well represented in the literature. Hippocampus had been used in many physiology
studies because of its role in e.g. learning and memory, whereas the striatum involved e.g.
in the development of drug dependence was often used in pharmacology/toxicology
studies. Cell cultures were used the second most often (94 studies). Whole brain was used
in 57 studies although the use of whole brains may mask regional expression changes.
Single isolated cells were used in only nine studies as the isolation requires special
techniques and amplification of RNA. One study used voxelation in which the brains were
cut into equal-sized cubical parts to be profiled separately.
5.1.3 Experimental designs often lacked replicates
About half of the studies did not state using any biological replicates. In the studies that did
use biological replicates, there were usually 2 to 10, most typically 3 replicates. Each
biological replicate was often an individual animal or cell culture but in about 38 % of the
studies, samples derived from several animals were pooled likely to obtain a sufficient
amount  of  RNA.  It  can  also  be  argued  that  a  sample  pooled  from  several  individuals
represents the population better than a sample from a single animal if biological replicates
are not used. Technical replicates were used even more rarely. About 72 % of the studies
did not report to use them at all. Sometimes the sample was hybridized onto two replicate
chips,  more  rarely  onto  three  or  four  chips.  However,  some microarray platforms contain
targets spotted on the array in duplicate, which provides a measure of the variation in
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hybridization. The number of replicates or details in description of methods did not change
over the years from 1999 to 2004.
Economical reasons may limit the number of replicates used, as the commercial
microarrays have been relatively expensive. In some cases scarcity of tissue can also limit
the use of replicates. Experimental designs were often complex involving several
treatments, genotypes, time points etc. and the use of replicates would obviously have
multiplied the already large number of microarrays required. However, the lack of
biological replicates is surprising considering their necessity for the calculation of
appropriate statistics. Technical replicates are not as important as biological replicates in
order to obtain biologically relevant information although they help to handle possible
variations arising from e.g. differential labelling efficiencies, uneven hybridizations or
technical differences between microarrays.
5.1.4 Platforms, imaging systems and analysis software
Microarrays were obtained from commercial sources in 76 % of the studies. Among the 15
commercial platform manufacturers reported, the most commonly used was Affymetrix
(184 studies) followed by Clontech (97 studies, I, Figure 2A). The non-commercial
microarrays were mainly custom microarrays designed by the laboratories (105 studies).
The distinction was not made whether they were produced by the laboratory itself or by a
commercial or academic facility. The proportion of custom microarrays remained
approximately the same over the years 1999-2004 and they were made for both commonly
and rarely used model organisms. Microarrays were purchased directly from microarray
core  facilities  located  in  non-profit  academic  institutions  or  organizations  in  only  three
studies despite the apparent cost advantage compared to commercial microarrays. This
may  be  due  to  a  more  limited  selection  of  microarray  types  available.  Some  microarrays
contained probes for only a few selected genes whereas some represented entire genomes
containing up to 65000 probes.
Several scanning systems and image quantification software (I, Figure 2B) as well as
data analysis software were used. The scanning systems reported were by about 20
different manufacturers. There were about 50 different image quantification software and
100 data analysis software reported. As in the case of microarray platforms, mostly
commercial software were used. The use of the same manufacturer’s microarray platforms,
analysis instruments and software was usually preferred when possible. The two most
frequently mentioned companies Affymetrix and Clontech provided integrated tools for
image and data analysis, which may be one reason for their popularity. The data shows that
a leader on the market can become a generally accepted “standard”. However, even when
an integrated platform and analysis system were used, one data set was often analyzed
with  more  than  one  data  analysis  tool,  e.g.  one  for  calculating  the  fold  change,  one  for
statistical tests, one for clustering, one for visualization, and one for formatting the data to
be imported from a software to another. Among the data analysis software, there were also
about 20 non-commercial programs the most common of which was Michael Eisen’s
software “Cluster” used in 21 studies.
5.1.5 Microarray data was not effectively shared in the early years of the technology
Full data set containing information for all features measured in each condition was
available for only 53 out of the 448 studies. The data was most often published on the
author’s or institute’s website (29 studies) or as supplementary material of the journal (11
studies). In 13 studies the data was deposited in a public database that was GEO in 7
studies, Array Express in 3 studies, Neumetrix in 2 studies, or China Medical College
database in one study. In two additional studies it was stated that the data was available
upon request directly from the authors, which may apply to many other studies as well. In
most  studies,  typically  only  the  differentially  expressed  genes  were  listed  although  the
criteria  of  differential  expression  were  not  uniform  making  it  difficult  to  compare  the
results between different studies.
Data on author’s or institute’s website is often available only for a limited time whereas
journals and databases likely hold it longer. However, the Neumetrix and China Medical
College databases are not available anymore. Full data sets were presented usually as
output from software, either as raw data or processed data. The format depends on the
software used. In rare cases even scanned microarray images were published.
In the beginning, MIAME referred only to the information on the microarray experiment
and not to the data itself. Now also the data sets in both raw and processed forms are
considered an essential part of MIAME. GEO and Array Express databases support and
encourage the submission of MIAME compliant data. The ten studies in which data was
deposited to  either  GEO or  Array Express  should be  MIAME compliant  and two of  these
are explicitly stated to be MIAME compliant. However, data in these studies is usually
available either in raw or processed form, not both. Also the information directly accessed
through the databases often lacks information such as descriptions of data analysis. Four
studies contained a microarray experiment description in a MIAME-compliant format in a
separate document but the whole data sets were not available. In other studies, including
those with the datasets available on authors’ websites or supplementary material, the only
source of information on the experiment was the article itself. Public deposition of
microarray data appears to have improved a great deal as the public databases GEO and
Array Express currently have tens of thousands of datasets related to neuroscience.
5.2 AHR-1 MUTANT C. ELEGANS
The function of AHR-1 was investigated in C. elegans using mutants that lack the functional
AHR-1 protein. First, effects of the mutation on growth and behavior were observed. The
hypothesis was that AHR-1 might play a role in the regulation of fatty acid diversity in C.
elegans as  it  had earlier  been shown to  be  involved in  the  transcriptional  regulation of  fat
metabolism enzymes in mouse liver (Boverhof et al., 2005; Sato et al., 2008). The overall
fatty acid compositions were measured as well as transcriptional alterations of genes that
maintain fatty acid diversity. Finally, global transcriptomic alterations due to the lack of
functional AHR-1 were investigated in the L1 larval stage using microarrays and in the L4
larval stage using RNA-seq.
5.2.1 Mutant alleles of ahr-1
Two available C. elegans strains carrying different mutant alleles of ahr-1 were used, namely
ia03 and ju145 (IV, Figure 1). The ia03 allele has a 1517 bp deletion that removes exons 4 to
7 and causes a premature stop codon in exon 8, while the ju145 allele  has  a  C to  T  point
mutation in exon 7 leading to a premature stop codon in place of the amino acid 302. If the
mutant ahr-1 alleles are translated into truncated proteins both of them contain the bHLH
domain responsible for DNA binding and parts of the sequence that forms the PAS-B
domain. The ju145 mutant protein would contain the sequence for a full PAS-A domain
whereas the ia03 mutant  protein  would  lack  it  completely.  Any  carboxyterminal
transcriptional activation regions would be missing from both of the mutant proteins. Thus,
the truncated proteins should lack the transcriptional activation function of AHR-1.
However,  there  is  still  a  possibility  that  they  could  bind  DNA  to  repress  transcription  or
function through some other mechanism resulting from protein-protein interactions. The
remaining functions may differ between the two mutant proteins and explain the
phenotypic and transcriptomic differences between the mutant strains.
5.2.2 Slow growth, movement, egg laying and defecation
The role of AHR-1 in neuronal development had been demonstrated earlier by Qin and
Powel-Coffman (2004) and Huang et al. (2004) but little was known about other phenotypes
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of the ahr-1 mutant C. elegans. Development was studied in ahr-1(ju145) mutant (II, Figure
3) and behavioral phenotypes were characterized in both ahr-1(ju145) and ahr-1(ia03)
mutants (II, Table 1). The ahr-1(ju145) mutant grew slower than wild-type as the time from
L1 to L4 larval stage was 6 h longer. Both of the ahr-1 mutants moved slower than wild-
type. They also defecated in a slower rhythm and laid fewer eggs in 4 hours than wild-type
and there was a small but significant increase in embryonic lethality. Brood sizes of the ahr-
1(ju145) mutant were also slightly smaller than those of wild-type although the difference
was not statistically significant.
Slow larval  development  or  embryonic  lethality  had not  been reported in  earlier  RNAi
studies (Fraser et al., 2000; Rual et al., 2004; Sönnichsen et al., 2005). The differences may
have  been  too  subtle  to  be  reported  or  detected  in  these  genomic  level  screens,  or  RNAi
may  not  have  silenced  the  gene  sufficiently.  The  involvement  of  AHR-1  in  movement,
defecation cycle or egg laying had not been studied before, except that the silencing of the
ahr-1 gene with RNAi had been shown to suppress the egg laying defect of another mutant
(Gort et al., 2008).
Locomotion, egg laying and defecation behaviors are controlled by specific motor
circuits in C. elegans. The well-characterized developmental defect in the GABAergic RME
motor neurons in ahr-1 mutant C. elegans (Huang et al., 2004) does not completely explain
the  behavioral  phenotypes  observed,  as  the  affected  behaviors  are  controlled  by  other
classes of motor neurons. However, the ahr-1 gene is mainly expressed in sensory neurons
and interneurons (Qin and Powel-Coffman, 2004) that can modulate activities in the motor
neurons as a response to environmental cues. For example, HSN motorneurons that control
egg laying receive sensory input from PLM mechanosensory neurons (Schafer, 2005) that
express ahr-1.
5.2.3 Alterations in fatty acid compositions and expression levels of fatty acid elongase
and desaturase genes
Ligand-activation of AHR had earlier been shown to alter gene expression of fat
metabolism enzymes in mouse liver (Boverhof et al., 2005; Sato et al., 2008) but a more
precise role in the regulation of fatty acid composition had not been investigated. In II,
relative amounts of different fatty acids were measured in ahr-1(ju145) mutant and wild-
type C. elegans (II, Figure 1). The proportions of 15-methylpalmitic (17isoA), elaidic
(18:1n9trans), dihomo-·-linoleic (20:3n6) and arachidonic (20:4n6) acids were significantly
increased, whereas the proportion of oleic acid (18:n9cis) was significantly decreased. The
increased arachidonic acid (20:4n6) is a precursor of epoxy and hydroxyl products made by
CYPs also in C. elegans (Kulas et al., 2008; Kosel et al., 2011).
The relative amounts of different fatty acids are controlled by desaturase and elongase
enzymes that in C. elegans are named FAT and ELO, respectively (Watts and Browse, 2002).
Gene expression of several fat metabolism-related genes is controlled e.g. by the nuclear
hormone receptor NHR-49 and the Mediator subunit MDT-15 (Van Gilst et al., 2005a, b,
Taubert et al. 2006). To understand the mechanisms underlying the changes in the fatty acid
composition, the expression levels of the genes fat-1, fat-2, fat-3, fat-4, fat-5, fat-6, fat-7, elo-1,
elo-2, elo-5, elo-6, nhr-49 and mdt-15 were measured in L4 larval stage C. elegans using qRT-
PCR. The elo-5, fat-7, nhr-49, and mdt-15 genes  were  over-expressed  in  the ahr-1 mutant
while the other genes studied were not altered significantly (II, Figure 2A). The increase in
elo-5 gene expression is consistent with the observed increase in 15-methylpalmitic acid
(17isoA) observed in ahr-1(ju145) mutant (II,  Figure 1) as ELO-5 catalyses the synthesis of
17iso from 15iso (II, Figure 2C). The expression of fatty acid desaturase and elongase genes
was measured also in L1 stage using qRT-PCR. In this stage, the elo-2, elo-5, fat-2, and fat-4
genes  were  over-expressed  and  the fat-5 and fat-7 genes under-expressed in the ahr-1
mutant (II, Figure 2B).
Activation of AHR by TCDD has later been shown to alter fatty acid compositions and
the expression levels of fatty acid-modifying genes also in mouse and rat liver (Angrish et
al., 2011; Forgacs et al., 2012). In mouse this is partially due to over-expression and
increased activity of the stearoyl-CoA desaturase SCD1 (Angrish et al., 2011) that catalyzes
the desaturation of e.g. 18:0 into 18:1n9. In C. elegans this reaction is catalyzed by FAT-7,
FAT-6 and FAT-5 that are also the closest homologs of mouse SCD1 in C. elegans.
Chromatin immunoprecipitation high-throughput DNA sequencing (ChIP-seq) data and
band shift assays suggest that AHR regulates SCD1 directly in mouse (Angrish et al., 2011).
In C. elegans, however, anatomical expression patterns of the differentially expressed genes
fat-7, elo-5, nhr-49, mdt-15, elo-2, fat-2 and fat-5 do not largely overlap with that of ahr-1
(Kniazeva et al., 2003, 2004; Huang et al., 2004; Qin and Powell-Coffman, 2004; Van Gilst et
al. 2005a, b; Brock et al., 2006; Hunt-Newbury et al., 2007; McGhee et al., 2007) suggesting
that the regulation of these genes in the ahr-1 mutant is indirect. However, it should also be
noted that these anatomical expression patterns obtained using promoter-GFP constructs
may not be entirely accurate as the “promoter” areas in the constructs can lack regulatory
elements located elsewhere in the genome (Hunt-Newbury et al., 2007).
Defects in fat metabolism affect several biological processes. Similar phenotypes as
observed in the ahr-1 mutant can be seen when the different genes required in fatty acid
metabolism  are  silenced  with  RNAi.  Earlier  RNAi  studies  show  that nhr-49, mdt-15, fat-7,
elo-5, elo-2, fat-2 and fat-5 genes are required in normal growth rate (Gönczy et al., 2000;
Kamath et al., 2003; Simmer et al., 2003; Kniazeva et al., 2003, 2004; Sönnichsen et al., 2005;
Lehner et al., 2006; Horikawa et al., 2008), nhr-49, fat-2 and fat-7 genes in movement
(Simmer et al., 2003; Yang et al., 2006; Horikawa et al., 2008), nhr-49, mdt-15, fat-7, elo-2, and
fat-2 genes in embryonic survival (Maeda et al., 2001; Kamath et al., 2003; Simmer et al.,
2003; Rual et al., 2004; Lehner et al., 2006; Horikawa et al., 2008), elo-2, fat-2 or fat-7 genes in
egg laying (Horikawa et al., 2008) and elo-2 gene in the regulation of the defecation cycle
(Kniazeva et al., 2003).
5.2.4 Gene expression profile in L1 larval stage using microarrays
Transcriptomic alterations due to the lack of functional AHR-1 protein were measured on a
whole-genome level in L1 larval stage C. elegans using microarrays. In total, 238 genes were
over-expressed and 324 genes under-expressed in the ahr-1(ju145) mutant compared to
wild-type (II, Supplementary Table 2).  While the C. elegans AHR homolog does not bind
TCDD, the results from our microarray study surprisingly suggest that the ahr-1 gene still
affects the expression of genes related to xenobiotic metabolism and the direction of the
expression change was also unexpected: the most over-expressed genes included the Phase
I and II metabolic enzyme genes cyp-13A4, ugt-19, and gst-21 (II,  Table  2)  and  the  over-
expressed genes included also cyp-35A5, ugt-20, ugt-22, ugt-29, ugt-33, ugt-38, ugt-41 and
gst-31 (II, Supplementary Table 2). However, a clear majority of the affected genes were
not related to xenobiotic metabolism, but rather to physiological functions (II,
Supplementary Tables 2 and 3). The most under-expressed genes included the fatty acid
desaturase gene fat-7 and the enoyl-CoA hydratase ech-6 that is required for the catabolism
of fatty acid to acetyl CoA and energy (II, Table 2).
Enriched Gene Ontology (GO) level 3 Biological Process (BP) and Molecular Function
(MF)  terms as  well  as  PANTHER BP and MF terms were  found for  the  over-  and under-
expressed genes (II, Supplementary Table 3).  Enriched  BP  terms  among  the  over-
expressed genes were associated with carbohydrate metabolism or synaptic transmission.
Enriched MF terms among the over-expressed genes were also mainly related to
metabolism, such as transferase or oxidoreductase activity, but included also protein
binding, calcium binding, mitochondrial carrier protein or cytoskeletal protein.
Among the under-expressed genes, many enriched BP terms were associated with
growth and development (II, Supplementary Table 3), which is consistent with the slow
larval development observed in the ahr-1(ju145) mutants (II, Table 1). One of the enriched
GO BP terms was “locomotory behavior” consistent with the slow movement phenotype of
the ahr-1 mutant  (II,  Table  1). Also genes required in reproductive development were
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under-expressed in the ahr-1 mutant. Other enriched BP terms among the under-expressed
genes were associated with cellular biosynthesis and catabolism, homeostasis, electron
transport, cell surface receptor-mediated signaling, and metabolism of several types of
compounds such as alcohols, organic acids, amines, amino acids, nitrogen compounds and
pyrimidines. Most of the enriched MF terms were related to enzymatic activity such as
peptidase, oxidoreductase, hydrolase, small GTPase, metalloprotease, transferase, and
coenzyme or heme binding.
This data suggests that the loss of function of AHR affects similar processes in C. elegans
as previously observed in mammals. Knockout of AHR has been shown to affect the
expression  of  several  genes,  many  of  which  have  metabolic  and  enzymatic  functions,  in
mouse liver (Tijet et al., 2006; Minami et al., 2008; Boutros et al., 2009; Reyes-Hernández et
al., 2010), mouse kidney (Boutros et al., 2009), or rat liver (Boutros et al., 2011). Overall, the
data reveals a widespread role for AHR-1 during early larval development.
5.2.5 Gene expression profile in L4 larval stage using RNA-seq
Gene expression profile alterations were also measured in L4 larval stage in ahr-1(ia03) and
ahr-1(ju145) mutants compared to wild-type nematodes using RNA-seq. Initially, 51 to 61
million reads were obtained in each sample of which 85 to 88 % aligned directly to the C.
elegans “virtual transcriptome” compiled based on known gene models in TopHat
(Langmead et al., 2009, IV,  Table  1). The expression levels were calculated for 45343
predicted transcripts as expected fragments per kilobase of transcript per million fragments
sequenced (FPKM) using Cufflinks (Trapnell et al., 2010). Over 18000 transcripts were
detected in each sample (IV, Figure 2 A and B).
Fourteen (14) transcripts were over-expressed and 125 transcripts under-expressed in
both of the ahr-1 mutants when compared to wild-type (IV,  Figure  2  C  and  D,  Table  2,
Supplementary files 1 and 2). In total, 198 transcripts were over-expressed and 318
transcripts under-expressed in the ahr-1(ia03) mutant (IV, Supplementary file 1) while 41
transcripts were over-expressed and 487 transcripts under-expressed in the ahr-1(ju145)
mutant compared to wild-type (IV, Supplementary file 2). There was only little overlap in
the differentially expressed genes between the L1 and L4 stages (II, IV). This was expected
since gene expression greatly depends on the developmental stage (Agarwal et al., 2010).
5.2.5.1 gcy and fbxa family genes and nlp-20 were under-expressed
The most under-expressed genes included the soluble guanylate cyclase genes gcy-32 and
gcy-36, the neuropeptide-like protein gene nlp-20 and  the  F-box  A  protein  genes fbxa-191,
fbxa-192 and fbxa-193 (IV, Table 2). The under-expression of gcy-36, nlp-20 and fbxa-192 was
confirmed with qRT-PCR in both mutant strains and that of fbxa-191 and fbxa-193 in the ahr-
1(ia03) mutant (IV, Figure 3). gcy-32 was detected in only two replicates of the ahr-1(ia03)
mutant and not at all in the ahr-1(ju145) mutant in qRT-PCR although it was detected in all
of the four wild-type samples. This is likely due to a low level of expression in the mutant
strains as observed in RNA-seq (IV, Supplementary files 1 and 2). In addition, gcy-33, gcy-
35 and gcy-37 were significantly and over 2-fold under-expressed in the ahr-1(ju145) mutant
which was also confirmed with qRT-PCR (IV, Figure 3).
The finding that several gcy family genes were significantly under-expressed is in
agreement with previous studies performed with promoter-GFP fusion constructs showing
that gcy-32, gcy-34, gcy-35, gcy-36 and gcy-37 are down-regulated in ahr-1 mutants (Qin and
Powell-Coffman, 2004; Qin et al., 2006). All of the gcy genes  altered  in  the ahr-1 mutant,
except gcy-33, are expressed in neurons that also express ahr-1 (Yu et al., 1997b; Cheung et
al., 2004; Gray et al., 2004; Qin et al., 2006). RNA-seq was sensitive enough to detect
expression differences of these genes although they have been detected in only 2-20 cells in
the promoter-GFP studies and total RNA for RNA-seq was extracted from whole animals.
A similar sensitivity of C. elegans whole-animal RNA-seq to detect differences in expression
even  for  genes  expressed  in  only  a  few  cells  was  seen  also  in  another  study  from  our
laboratory (Peltonen et al., 2013).
Another dramatically under-expressed gene in ahr-1 mutants, nlp-20, encodes  a
neuropeptide-like protein whose receptor is unknown and whose knockdown by RNAi
leads to embryonic lethality. nlp-20 is expressed in four head neurons, four tail neurons, one
pharyngeal neuron, spermatheca, and intestine (Nathoo et al., 2001). Although ahr-1
modulates social feeding behavior in npr-1 mutants (Qin and Powell-Coffman, 2004) it is
not likely that NLP-20 is a ligand of NPR-1 since the two known ligands for NPR-1, FLP-18
and FLP-21, are FMRFamide-related neuropeptides, a neuropeptide class distinct from
NLPs (Li et al., 1999; Rogers et al., 2003). NLP-20 may be part of another neuronal pathway
that mediates social feeding or other AHR functions such as movement or neuronal
development. Interestingly, among the most under-expressed genes in L1 stage ahr-1
mutants there was another neuropeptide gene, nlp-30 (II,  Table  2),  suggesting  a  role  for
AHR-1 in neuropeptide regulation also in the earliest larval stage. In addition, TCDD has
been shown to affect the expression of neuropeptides in rat neurons through AHR (Fetissov
et al., 2004; Solak et al., 2013).
A novel role for AHR-1 transcription is the regulation of proteins that contain F-box
motifs. fbxa-191 and fbxa-193 are pseudogenes whereas fbxa-192 is protein-coding.
Pseudogenes, mutated genes that no longer encode a functional protein, were originally
considered to be junk DNA and to eventually degenerate due to accumulating mutations in
the absence of selection pressure. More recent studies suggest that transcribed pseudogenes
can regulate RNAs from the corresponding functional genes by binding to them as
antisense RNAs, producing small interfering RNAs or competing for factors that regulate
mRNA stability such as microRNAs (reviewed by Pink et al., 2011). The coordinate
regulation of three similar fbxa genes of which two are pseudogenes and one is protein-
coding may be due to a conserved regulatory sequence. Alternatively, the transcripts may
affect the levels of each other. One such example is the phosphatase and tensin homolog
(PTEN)  tumor  suppressor  gene  that  is  regulated  negatively  and  positively  by  different
transcripts from its pseudogene PTENpg1 (Poliseno et al., 2010; Johnsson et al., 2013). The
extent to which AHR-1 controls non-coding RNA expression remains to be determined.
However, about 12 % of the under-expressed transcripts were pseudogenes or other non-
coding RNAs (data not shown).
5.2.5.2 Putative XRE sites upstream of the under-expressed genes
The XRE core sequence GCGTG was searched in 2000 bp 5’ flanking sequences of the gcy,
nlp-20 and fbxa genes. Putative XREs were found in front of nlp-20, gcy-32, gcy-33, gcy-35,
fbxa-191 and fbxa-192 (IV, Figure 4) supporting the idea that AHR-1 induces these genes via
binding to the conserved XRE sequence. The different known isoforms for the nlp-20, gcy-33
and gcy-35 genes have different transcription start sites and therefore the putative XREs are
in different locations for them, sometimes in introns of the other isoforms (IV,
Supplementary file 3). The closest putative XRE site for fbxa-193 is 2164 bp upstream of the
transcription start site (data not shown). gcy-36 does not have a GCGTG pattern in its 2000
bp  flanking  sequence  but  has  one  in  its  5’UTR  (data  not  shown)  which  likely  is  the  one
found earlier by Qin et al. (2006).
In the study by Qin et al. (2006), a gcy-35 5’ flanking sequence of 1250 bp as well as a gcy-
36 5’ flanking sequence of 1172 bp were sufficient to drive GFP transgene expression in
wild-type background and the expression was significantly decreased in ahr-1(ia03)
mutants. Similarly in IV, nlp-20 5’ flanking sequence of ~1800 bp was sufficient for GFP
transgene  expression  in  the  presence  of  wild-type ahr-1,  and  the  expression  was
significantly reduced in ahr-1(ia03) mutant background. This suggests that AHR-1 regulates
nlp-20, gcy-35 and gcy-36 genes  through  these  flanking  sequences.  However,  a  point
mutation  of  the  XRE  in  the gcy-35::GFP or gcy-36::GFP transgenic constructs did not
diminish the GFP transgene expression in wild-type, suggesting that the predicted XRE
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sites are not necessary for transcriptional activation of gcy-35 or gcy-36 by AHR-1 (Qin et al.,
2006). The point mutation used by Qin et al. (2006) may not be sufficient to abolish the
binding of AHR-1:AHA-1 heterodimer in vivo although it does so in vitro (Powell-Coffman
et al., 1998), or the regulation of gcy-35 and gcy-36 by  AHR-1  may  be  indirect  or  involve
another AHR-1 binding sequence.
5.2.5.3 Two catalase genes were modestly over-expressed
There were far fewer over-expressed than under-expressed genes in the ahr-1 mutants (IV,
Figure 2 C and D). The over-expressed genes in both ahr-1 mutant strains included two
catalase genes ctl-1 and ctl-3. Over-represented GO level 5 terms among the 14 over-
expressed genes were “cellular response to reactive oxygen species”, “hydrogen peroxide
catabolic process”, “response to hydrogen peroxide” and “catalase activity”, and each term
involved only the two catalase genes (IV, Supplementary file 4). AHR has been previously
associated with the induction of genes in the oxidative stress pathway in higher organisms
(Nebert et al., 2000; Dalton et al., 2002). However, in IV only  two  genes  in  the  pathway
were differentially expressed, and their over-expression in the mutants suggests that AHR-
1 represses rather than induces these genes. The over-expression of ctl-1 and ctl-3 was
modest: 3.0 to 4.5-fold in RNA-seq and 1.3 to 1.8-fold in qRT-PCR (data not shown).
Catalase activity was not significantly increased in either ahr-1(ia03) or ahr-1(ju145) mutants
when compared to N2 (data not shown). The data does not strongly support activation of
oxidative stress pathways via AHR-1 in C. elegans and it is therefore possible that the role of
AHR in oxidative stress observed in higher organisms has evolved separately from C.
elegans.
5.3 C. ELEGANS CYP-35A SUBFAMILY
Earlier studies have indicated a role of cyp-35A subfamily members 2, 3, 4 and 5 in the
regulation of C. elegans fat storage (Ashrafi et al. 2003, Menzel et al. 2007). In III, the effect
of the cyp-35A subfamily genes 1, 2, 4 and 5 on fatty acid regulation was studied at multiple
levels using mutants lacking the functional CYP-35A proteins. First, fat content was
visualized in  the  mutants  and wild-type.  To investigate  the  role  of  the cyp-35A subfamily
genes on the regulation of the diversity of fatty acids molecules, relative amounts of several
fatty acids as well as expression level alterations of genes that control their proportions
were measured. Also the levels of the endocannabinoids AEA and 2-AG in the cyp-35A
subfamily  mutants  and the  effect  of  dietary fatty  acids  on the  gene expression of cyp-35A
subfamily members in wild-type C. elegans were measured. In addition, protein sequences
of human and C. elegans CYPs were compared.
5.3.1 Sequence alignments of human and C. elegans CYPs
Peptide sequences of human and C. elegans CYPs were compared to construct a
phylogenetic tree showing the relations of the different CYPs (III, Figure 1). The C. elegans
CYPs clustered in four major sets that corresponded to the currently accepted clans found
in nematodes, i.e. 2, 3, 4 and mitochondrial (Baldwin et al., 2009). As most C. elegans CYP
families, the CYP-35 family is found in other nematode species such as C. briggsae and C.
remanei but not in vertebrate-, insect-, plant-, fungi-, or bacterial species investigated to date
(Nelson, 2009).
The C. elegans CYP-35 family belongs to clan 2 together with the human CYP1 and CYP2
families. This clan is diverse in both human and in C. elegans.  The CYP-35 family and the
CYP-35A subfamily are relatively large (ten and five members, respectively) and the cyp-35
genes are located in a cluster in the genome. This suggests that the cyp-35 genes have
undergone frequent duplications and losses during evolution likely in response to
changing xenobiotic exposure (Thomas, 2007). The role of CYP-35A members in xenobiotic
metabolism is also supported by studies showing that the cyp-35A family genes are induced
by a number of xenobiotics (Menzel et al., 2001, 2005, 2007; Kwon et al., 2004; Roh et al.,
2006, 2007, 2010; Chakrapani et al., 2008; Roh and Choi, 2011; Peltonen et al., 2013,). The
human CYP1 and CYP2 families metabolize xenobiotics and also a wide variety of
endogenous compounds including fatty acids and their derivatives (Nebert et al., 2013).
The CYP-35 family is also somewhat related to the C. elegans CYP-33E2 that metabolizes
fatty acids into signaling molecules (Kulas et al., 2008; Kosel et al., 2011).
The CYP-35A peptides are very similar to each other especially at the first 100 amino
acids from the N terminus and from amino acid 300 to 400 (III, Supplementary Figure 1).
Within the family, CYP-35A2 and CYP-35A3 are the most similar and CYP-35A1 the most
different in sequence. CYP-35A1 is missing a 38 amino acid sequence that the other four
CYPs have in the middle of the peptide chain (amino acids 254 to 291) while it has
additional amino acids closer to the C terminus.
5.3.2 Fat was reduced in cyp-35A1 and cyp-35A5 mutant C. elegans
To investigate the role of cyp-35A subfamily members 2, 3, 4 and 5 in the regulation of C.
elegans fat storage, fat content was visualized in cyp-35A1, cyp-35A2, cyp-35A4, and cyp-35A5
mutants and wild-type using Oil-Red-O (Soukas et al., 2009; Horikawa and Sakamoto,
2010) instead of Nile Red used in earlier studies (Ashrafi et al., 2003; Menzel et al., 2007). Fat
content was reduced in cyp-35A1 and cyp-35A5 mutants (III, Figure 2), which supports the
role of the CYP-35A subfamily in fat storage. The reduced fat in the lack of CYP-35A1 had
not been reported before, likely due to allelic differences. Fat content was reduced in the
cyp-35A1(ok2306) mutant (III) but not in the cyp-35A1(ok1414) mutant (data not shown) that
was also used by Menzel et al. (2007).
Unlike in the study by Menzel et al. (2007), any marked reduction in fat stores could not
be seen in cyp-35A2(gk317) or cyp-35A4(ok1393) mutants. The difference is most likely due to
the dyes that stain distinct, mostly nonoverlapping fat compartments. Nile Red stains the
intestinal acidic lysosome-related organelles (LROs) whereas Oil-Red-O stains neutral lipid
vesicles in the intestine, hypodermis, gonad, and eggs (O’Rourke et al., 2009). In fasting
conditions  and  several  mutants  Oil-Red-O  signal  correlates  with  triglyceride  mass
measured with biochemical assays whereas Nile Red signal does not (O’Rourke et al., 2009).
The cyp-35A2 and cyp-35A4 mutants may be depleted in Nile Red-positive LRO fat but not
in Oil-Red-O-positive lipid droplet fat. More sensitive methods such as solid-phase
chromatography followed by gas chromatography/mass spectrometry (O’Rourke et al.,
2009) could detect possible alterations in the total triglyceride content of the cyp-35A2 and
cyp-35A4 mutants.
Our results suggest that CYP-35A1 and CYP-35A5 are necessary, but not sufficient to
maintain fat storage. The molecular mechanism by which these CYPs act may be complex
as fat storage is influenced by several processes such as food sensation, feeding,
neuroendocrine control of metabolism, nutrient absorption and transport, de novo synthesis
of fatty acids, triglyceride production, lipid droplet/LRO formation, lipolysis, and energy
production from fats (Ashrafi, 2007). Genome-wide RNAi studies in C. elegans have
revealed 305 gene inactivations that reduce Nile-Red-positive body fat (Ashrafi et al., 2003).
These genes include metabolic enzymes, lipid interacting proteins, transcription factors,
signal transduction molecules, receptors, channels and transporters, energy metabolism
enzymes, cell surface molecules, vesicular transport proteins, protein degradation enzymes,
cytoskeletal proteins, and general cellular machinery proteins.
5.3.3 Fatty acid compositions and gene expression levels of enzymes that regulate them
were altered in the cyp-35A subfamily mutants
To investigate the possible role of the cyp-35A subfamily  genes  on  the  regulation  of  fatty
acid diversity, relative amounts of several different fatty acids were measured in the cyp-
35A subfamily mutants. Also gene expression levels of the fatty acid desaturase genes fat-1,
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fat-2, fat-3, fat-4, fat-5, fat-6 and fat-7 and the elongase genes elo-1, elo-2, elo-5, and elo-6 that
control the proportions of different fatty acids were measured in the mutants.
The fatty acid compositions showed modest but statistically significant changes (III,
Figure  3). The most affected fatty acid profiles were seen in the cyp-35A1 and cyp-35A5
mutants in which also fat content was reduced. Also gene expressions were mostly altered
in these two mutants (III, Figure 5A). The cyp-35A5 mutant differed from the other mutants
in  the  directions  of  the  changes:  its  fatty  acids  were  slightly  shifted towards longer  chain
fatty acids whereas in the other mutants the trend was opposite. In addition, all of the
genes measured appeared under-expressed in the cyp-35A5 mutant (decreases in fat-1 and
fat-3 being statistically significant) whereas in the other mutants, particularly cyp-35A1, the
same genes were over-expressed.
The differentially expressed fat and elo genes are regulated by transcription factors such
as NHR-49, SBP-1 or DAF-16 (Kamath et al., 2003; Murphy et al., 2003; Van Gilst et al.,
2005a, b; Kniazeva et al., 2008). One possible mechanism for the altered gene expression is
that the CYP-35A members synthesize or degrade ligands for such transcription factors.
Some of the gene expression changes of the enzymes appear to explain the alterations in
the levels their fatty acid substrates or metabolites (III, Figure 5B). For example, ·-linoleic
acid (18:3n6) is increased in the cyp-35A1 mutant and the fat-3 gene encoding the enzyme
that synthesizes it is over-expressed. However, not all alterations appear concordant in the
same sense. For example, the over-expression of the fat and elo genes in the cyp-35A1
mutant would suggest a shift towards longer and more unsaturated fatty acids but this was
not seen in its fatty acid composition. Alterations in gene expression levels of enzymes
precede (and not always predict) alterations in their protein levels or enzyme activities. The
fatty acids might also form feedback loops to control gene expression of the enzymes
responsible for their synthesis or metabolism. Thus, the alterations seen in the assays may
depend on timing issues.
Overall, the alterations in the fatty acid compositions were small considering the obvious
reduction  of  fat  in cyp-35A1 and cyp-35A5 mutants. Possible local alterations may be
diluted, as whole animals were used and different tissues or subcellular fractions were not
separated. Alternatively, the small changes might reflect a strong metabolic drive to
maintain the diversity of fatty acids. It is possible that other factors, such as those that cause
the reduced fat phenotype, also affect amounts of specific fatty acids and the gene
expression alterations of the fat and elo enzymes are a homeostatic response to compensate
these changes. Moreover, major changes in fatty acid composition profiles are typically seen
only in C. elegans mutants lacking enzymes required for fatty acid desaturation or
elongation (Watts and Browse, 2002; Kniazeva et al., 2004) while changes are more
moderate in e.g. mutants lacking transcription factors that regulate genes in the fatty acid
metabolism pathways (Van Gilst et al., 2005a, b; Taubert et al., 2006; II).
The acs-2 gene that encodes the fatty acid CoA synthetase 2 enzyme required in the first
step of fatty acid Ά-oxidation was only slightly over-expressed in the cyp-35A2 mutant (fold
change 1.7) and under-expressed in the cyp-35A5 mutant (fold change 0.8), and unaffected
in cyp-35A1 and cyp-35A4 mutants. The results do not indicate increased usage of fatty acids
for energy in Ά-oxidation in the cyp-35A mutants that would explain the depletion of fat
stores.
5.3.4 The endocannabinoid AEA was increased in the cyp-35A5 mutant
The endocannabinoids AEA and 2-AG are arachidonic acid-containing signaling molecules
that control e.g. food intake and fat synthesis in mammals. Levels of AEA and 2-AG were
measured in the cyp-35A subfamily  mutants.  AEA  was  increased  4.6-fold  in  the cyp-35A5
mutant when compared to wild-type, but unaltered in the other cyp-35A mutants  (III,
Figure 4). 2-AG was not significantly altered in any of the cyp-35A mutants tested.
One hypothesis is that CYP-35A5 could metabolize AEA as some mammalian CYPs have
been shown to do in earlier studies (Bornheim et al., 1995; Snider et al., 2007, 2008; Stark et
al., 2008; Pratt-Hyatt et al., 2010). In C. elegans, the degradation of AEA depends on the
FAAH ortholog FAAH-1 (Lucanic et al., 2011). Therefore it seems unlikely that AEA
catabolism would also require CYP-35A5 as an AEA-metabolizing enzyme. Rather,
enzymes of AEA synthesis and/or degradation could be regulated in the cyp-35A5 mutant.
AEA signaling is also connected to the regulation of energy homeostasis. It increases
feeding and fat content in mammals (Matias and Di Marzo, 2007; Maccarrone et al., 2010).
In C. elegans, AEA and other NAEs mediate the signal of nutrient availability: Dietary
restriction leads to a decrease in NAE levels that is necessary for metabolic alterations
involved in dauer formation and longevity (Lucanic et al., 2011). Metabolic alterations
during dauer formation include also fat accumulation (Watts, 2008). Whether the increased
AEA  could  be  a  homeostatic  response  or  part  of  an  underlying  mechanism  causing  the
reduced internal fat stores observed in the cyp-35A5 mutant remains to be investigated.
5.3.5 Feeding with oleic and elaidic acids decreased the expression of cyp-35A subfamily
genes in wild-type C. elegans
Gene expression of the CYP35A subfamily members was investigated in response to
feeding of fatty acids. Diet affects CYP activities in mammals (Murray, 2006) and for
example high-fat diet has been shown to lower the gene expression of a CYP in mouse liver
(Yoshinari et al., 2006). Wild-type C. elegans were  fed  with  oleic  (18:n9cis) and elaidic
(18:1n9trans) acids that are not present in the standard OP50 E. coli diet but have been
detected in C. elegans (II, Figure 1). Feeding of oleic or elaidic acid in triglycerides lowered
the expression levels of the cyp-35A2, cyp-35A4, and cyp-35A5 genes whereas the cyp-35A1
gene was not  differentially  expressed (III,  Table  1). There was no difference between the
effect of the cis and trans forms on cyp-35A subfamily gene expression.
Similar feeding of oleic and elaidic acids in triglycerides has been shown to result in an
altered expression of some fat metabolism genes in C. elegans, including the fatty acid
desaturase fat-7, the fatty acid Ά-oxidation gene acs-2, the transcriptional regulator genes
mdt-15 and daf-16 and a steroid dehydrogenase gene let-767 that  is  also  involved  in  the
production of fatty acids (Reisner et al., 2011). Our result supports the hypothesis that the
CYP-35A subfamily members function in the same or parallel pathways with these genes to
regulate fat metabolism in response to dietary fatty acids.
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6 Summary and conclusions
The aims of the present study were to investigate the basic physiological roles of AHR and
CYPs in C. elegans and follow the development of gene expression profiling methods and
their usage. Loss-of-function mutants were studied using a combination of phenotyping,
fatty acid profiling and transcriptomics approaches.
To summarize the main findings:
1. Systematic analysis of neuroscience publications between years 1999 and 2004 revealed a
growing trend in the application of microarrays in gene expression profiling experiments
that has continued until recent years (I).  The  use  of  RNA-seq  is  growing  although
microarrays may still be a more used method in neuroscience. Most of the animal species
used were relatively large vertebrates. Neuron-specific gene expression can be profiled also
in C. elegans with new techniques but it is far more challenging than the profiling of whole
animals. Microarray data in the neurosciences was not shared effectively during 1999-2004.
To  date,  the  situation  has  improved  as  public  databases  contain  tens  of  thousands  of
datasets related to neuroscience. However, the reporting of the experiments and especially
data  analysis  steps  as  well  as  the  inclusion of  both raw and processed data  could still  be
better.
2. The lack of functional AHR-1 affected neuromuscular behaviors including movement,
egg laying and defecation (II),  which  is  consistent  with  the  role  of  AHR-1  in  neuronal
development. Fatty acid compositions suggest a role for AHR in regulating the synthesis of
long-chain, unsaturated fatty acids, that eventually produce lipid signaling molecules. AHR
was also required for normal larval development rate. This is consistent with the gene
expression profile of L1 stage ahr-1 mutants that supports a role of AHR in growth, and also
in metabolism, homeostasis and signal transduction. In the L4 stage, AHR-1 regulates the
expression  of  genes  involved  in  neuronal  function  as  well  as  transcribed  pseudogenes  or
other noncoding RNAs (IV). Overall, the results suggest that many of the physiological
roles  of  AHR-1  are  conserved  despite  the  apparently  different  activation  of  AHR  in
vertebrates and invertebrates.
3. Members of the highly xenobiotic-inducible CYP-35A subfamily were required for the
normal accumulation of fat in C. elegans (III). They were demonstrated to have a role in the
dynamic regulation of the variety of different fatty acid molecules in the nematode. In
addition,  the  results  suggest  that  CYP-35A5  plays  a  part  in  the  regulation  of  the
endocannabinoid AEA levels in C. elegans. These results provide a framework for future
mechanistic studies to investigate fatty acid signaling using C. elegans. These findings also
predict an elaborate role for CYPs overall in regulating signaling molecules in higher
organisms.
Taken together,  many of  the  roles  of  AHR and CYPs are  conserved between C. elegans
and mammals and C. elegans can be used as a model in molecular toxicology. This
information on physiological roles of AHR and CYPs may help to understand the
mechanisms of action of their altered activity caused by mutations or toxins and should be
taken into consideration when assessing chemicals humans are exposed to or before
developing treatments against the undesired effects.
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Functions of AHR-1 and 
CYP-35A Subfamily Genes
in Caenorhabditis elegans
Aryl hydrocarbon receptor (AHR) 
is a transcription factor aberrantly 
activated by some toxins. Its target 
genes include cytochrome P450 
(CYP) enzymes. In this thesis, 
Caenorhabditis elegans is used to 
demonstrate a role for the AHR 
ortholog AHR-1 in neuronal function, 
growth and metabolism. Moreover, 
AHR-1 and Caenorhabditis elegans 
CYP-35A subfamily members are 
shown to take part in the regulation 
of fatty acid diversity and possibly 
lipid signaling. Many of the roles 
presented here appear conserved 
in mammals and may help to 
understand mechanisms of action of 
toxins.
